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THE ROLE OF CA2+/CALMODULIN DEPENDENT PROTEIN KINASE II, CaMK-II, IN 
KIDNEY MORPHOGENESIS 
By Sarah R. Ingram, B.A. 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
Virginia Commonwealth University, 2020 
Robert M. Tombes, Ph.D. 
Vice Provost, Life Sciences 
Sarah C. Rothschild, Ph.D. 
Assistant Professor, Life Sciences 
 
 Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common 
heritable diseases in the world, characterized by the development of large fluid filled cyst that 
inhibit kidney function. Treatments for this disease are currently limited due to a lack of 
understanding of disease pathogenesis. Ca2+/calmodulin dependent protein kinase II (CaMK-II) is 
necessary for kidney morphogenesis in zebrafish as well as being a downstream effector of pkd2, 
one of the genes most commonly mutated in ADPKD patients. The roles of CaMK-II during 
zebrafish kidney development include regulation of cell migration and pronephric convolution, as 
well as cloacal cilia stability. The influence of CaMK-II on these pathways is partially dependent 
on its regulation of HDAC4 localization. Inhibition of CaMK-II caused the translocation of 
HDAC4 from its location in the cytosol to the nucleus. This led to the model that CaMK-II 
activation via PKD2 retains HDAC4 in the cytosol allowing for transcription of its target genes. 
Notch signaling proteins were also identified to be potential members of this pathway as inhibition 
of CaMK-II caused a reduction in notch signaling in the cloaca as well as an increase in expression 
of the notch ligand deltaC. This increase in deltaC expression in embryos with inhibited CaMK-
II was rescued by suppression of hdac4. Further studies attempted with a zebrafish camk2g1 
xvi 
 
mutant proved inconclusive as mutants displayed none of the phenotypic defects seen in morphant 
embryos. Analysis of CaMK-II gene expression in camk2g1 mutants identified the capability of 
genetic compensation between CaMK-II isoforms. In camk2g1 mutants, the paralog gene camk2g2 
is upregulated over 3 fold, compensating for the loss of its paralog gene, thereby preventing the 
phenotypic defects typically seen in camk2g1 morphants. This compensation is not immediate as 
upregulation of camk2g2 was not seen in G0 camk2g1 CRISPR embryos. In conclusion, this study 
has not only furthered the understanding of the roles of CaMK-II during kidney development and 
identified new potential therapeutic targets for ADPKD patients, but it has also demonstrated the 
ability of CaMK-II isoforms to compensate for one other. In addition to providing a greater 
understanding of the relationship between CaMK-II paralogs, this study also further validates the 
uses of knockdown methods in developmental studies as compensation was found not to occur in 
these models.  
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Chapter 1: Background 
 
Polycystic Kidney Disease  
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common 
heritable diseases in the world (Igarishi and Somlo, 2002). In spite of its prevalence, no specific 
treatments exists due to a lack of understanding of its pathogenesis (Igarishi and Somlo, 2002). 
ADPKD is characterized by the development of large fluid-filled kidney cysts that gradually 
enlarge over time and replace healthy renal tissue (Igarishi and Somlo, 2002) (Kottgen, 2007). 
Cystic development can also occur in other organs such as the pancreas, liver, spleen, and ovaries 
(Gabow, 1993). This disease is thought to affect anywhere from 1 in 400 to 1 in 1000 individuals 
and is the fourth leading cause for renal replacement worldwide (Ong et al., 2015). 
 Initiation of cyst development in ADPDK patients requires a primary germline mutation in 
genes PKD1 and/or PKD2, as well as a secondary somatic mutation in either PKD1/PKD2 (Igarishi 
and Somlo, 2002). A PKD3 gene has been proposed in order to account for patients lacking 
mutations in PKD1 or PKD2 (Porath et al., 2016). A candidate for this gene is GANAB, which 
encodes for glucosidase II subunit α (Porath et al., 2016). Mutations in this gene have been shown 
to cause mild ADPKD and mild to severe autosomal dominant polycystic liver disease (ADPLD) 
(Porath et al., 2016).  However, mutations in GANAB only account for 3% of unresolved cases, 
implying that other genes are involved in ADPKD development in patients without mutations in 
PKD1 and PKD2 (Porath et al., 2016). 
 PKD1 codes for polycystin-1, a conserved membrane protein that is able to interact with 
a variety of other proteins such as lipids and carbohydrates (Wilson, 2006). PKD1 contains 
domains known to be involved in cell-cell and cell/matrix interactions (Chauvet et al., 2002). 
Expression of PKD1 can be seen in human fetal tissue samples in the neural tube, cardiomyocytes, 
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mesonephros, and endodermal derivatives (Chauvet et al., 2002). PKD1 expression can also be 
seen in differential proximal tubules during nephron development. Although many of the roles of 
PKD1 are still being elucidated, it is thought to have roles in transcription factor activation, G-
protein binding, regulation of Wnt signaling, as well as regulation of proliferation and resistance 
to apoptosis (Parnell et al., 1998) (Arnould et al., 1998) (Kim et al., 1999) (Boletta, 2000).  
 Approximately 85% of ADPKD cases are caused by mutations in PKD1 (He et al., 2011). 
These mutations can occur in a variety of forms including nonsense mutation, frame shift 
mutations, missense mutations, and aberrant splicing (He et al., 2011). It is thought that patients 
with mutations in the 5’ regions suffer from a more severe form of ADPKD than those with  
mutations in the 3’ region (He et al., 2011). Homozygous knockout of Pkd1 in mice causes severe 
renal cyst development and death by embryonic day 15 (He et al., 2011). Heterozygous mutants 
for Pkd1 are viable. However, they still exhibit renal and hepatic cyst development (He et al., 
2011) (Piontek et al., 2004). Loss of Pkd1 also causes other defects in mice including 
cardiovascular and skeletal defects (Boulter et al., 2001) (Kim et al., 2000).  
PKD2 encodes for polycystin-2 (TRPP2), a member of the TRP family of Ca2+ ion channels 
(Chauvet et al., 2002). PKD1 forms a complex with PKD2 enabling the formation of a non-
selective cation channel (Clapham 2003) (Mochizuki et al., 1996). In human tissue, PKD2 can be 
found in the plasma membrane, endoplasmic reticulum, and the primary cilium and has various 
functions depending on its location within the cell (Igarishi and Somlo, 2002) (Cai et al., 1999). 
In the plasma membrane, when complexed with PKD1, PKD2 functions as a non-selective cation 
channel with a higher selectivity for Ca2+ (Hanaoka et al., 2000) (Tsiokas et al., 2007). In the 
endoplasmic reticulum, PKD2 functions as an intracellular Ca2+ channel that is activated in 
response to alterations in intracellular Ca2+ levels (Cai et al., 1999) (Tsiokas et al., 2007). In the 
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primary cilium, PKD2 acts as a regulator of intracellular Ca2+ in response to fluid flow (Tsiokas et 
al., 2007) (Praetorius and Spring 2001). PKD2 has also been found in the mitotic spindle and 
centrosomes (Tsiokas et al., 2007). Although its exact function at these locations is not completely 
known, it is thought that it could be responsible for regulating Ca2+ levels during cell division 
(Rundle et al., 2004).  
Mutations in PKD2 account for approximately 15% of ADPKD cases (He et al., 2011). 
Typically, patients with mutations in PKD2 have a smaller number of cysts and don’t exhibit other 
symptoms until later in life. However, patients with mutations in PKD2 still suffer from a high 
frequency of renal failure with advanced age (Stypmann et al., 2007) (Hateboer et al., 2007). 
Homozygous and heterozygous mouse mutants for Pkd2 develop cysts in the kidneys and liver 
(Wu et al., 1998). In addition to cyst development, mouse mutants for Pkd2 also exhibit loss of 
left-right asymmetry, defects in reproductive tract development, and cardiovascular defects, a 
condition often seen in patients (Kuol et al., 2016) (Wu et al., 2000) (Pennekamp 2002) (Nie et al., 
2014).   
 
Zebrafish (Brachydanio rerio) as a Model Organism  
 The use of Brachydanio rerio, more commonly known as zebrafish, as a model organism 
originated in the 1970s with the work of George Streisinger. Zebrafish are a small freshwater 
cyprinoid fish that is thought to have originated in India, and can now be commonly found in pet 
stores around the world. Streisinger and his colleagues recognized the advantages of using 
zebrafish as a model for developmental and genetic studies, including their short generation time, 
high fecundity, external fertilization, and transparency during development (Streisinger et al., 
1981). Through their work using zebrafish, Streisinger and his lab were able to develop protocols 
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for using zebrafish for a variety of applications including cloning (Streisinger et al., 1981), 
mutagenic studies (Grunwald et al., 1988) and cell lineage tracing (Streisinger et al., 1988).   
 Since the work of Streisinger and his lab, zebrafish have become a staple in scientific 
research around the globe. The Sanger Institute started the zebrafish genome sequencing project 
in 2001 and has since created a full reference genome. (Howe et al., 2013). Zebrafish contain 25 
chromosomes (Postlethwait et al., 2000) and the zebrafish genome is thought to contain 26,206 
protein-coding genes (Howe et al., 2013). Of those protein-coding genes, approximately 70% are 
believed to have a human orthologue (Howe et al., 2013). The similarities between human and 
zebrafish genomes make the zebrafish a unique and essential tool for human medical research. 
 Zebrafish provide an excellent model to study kidney development due to common cell 
types and molecular pathways as well as their transparency during early development (Drummond 
and Davidson, 2010). During embryogenesis, zebrafish possess a pronephric kidney which 
consists of two pronephric ducts fused at the proximal end with the glomeruli and fused at the 
distal end with the cloaca (Drummond and Davidson, 2010).  In zebrafish, kidney cells are 
specified from the intermediate mesoderm at approximately 18hpf. The cells then undergo 
epithelialization at approximately 24hpf before migrating anteriorly via collective cell migration 
where they turn inward to connect with the glomerulus (Drummond and Davidson, 2010) 
(Vasilyev et al., 2009) This turning inward to connect with the glomerulus is known as ductal 
convolution and is thought to result from the piling up of cells at the anterior end (Vasilyev et al., 
2009). Angiogenesis then occurs and the pronephros are fully functional by 48hpf (Drummond 
and Davidson, 2010).  
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Zebrafish Models of Polycystic Kidney Disease  
 Zebrafish have proven to be a useful model for ADPKD caused by mutations in both pkd1 
and pkd2. Zebrafish models for pkd1 loss of function exhibit many defects in development. 
Inhibition of zebrafish paralogs pkd1a/pkd1b caused alterations in extracellular matrix proteins, 
hydrocephaly, craniofacial defects, and pronephric cyst development in a low percentage of 
embryos (10-15%) (Mangos et al. 2010).  Zebrafish with a loss of pkd1 also showed lymphatic 
system defects and cardiac edema by 5 days post fertilization (Coxam et al., 2014).  
Zebrafish models of ADPKD resulting from loss of pkd2 expression have also proven to 
be a valuable tool in understanding disease traits and progression. Like other models, 
downregulation of pkd2 results in the development of kidney cysts and defects in left-right 
asymmetry (Mangos et al., 2010) (Obara et al., 2006) (Schottenfeld et al., 2007). Other defects 
seen in zebrafish with a loss of pkd2 include hydrocephaly as well as body curvature, which is 
thought to result from alterations in the extracellular matrix (Mangos et al., 2010) (Obara et al., 
2006). Zebrafish injected with pkd2 mRNA that lack either the C-terminus or N-terminus 
dimerization domain also resulted in the formation of kidney cysts (Feng et al., 2008). 
 
Calcium Calmodulin Dependent Protein Kinase II (CaMK-II) 
CaMK-II is a serine/threonine protein kinase encoded by four genes in eukaryotes (α, β, γ, 
δ) (Tombes et al., 2003). CaMK-II forms oligomers of up to 12 subunits of which the subunits can 
be the same or different isomers (Bayer and Schulman, 2019). Each monomer of the holoenzyme 
consists of a catalytic, variable, and association domain (Tombes et al., 2003). The catalytic 
domain is 315 amino acids in length and contains the CaM binding domain. The variable domain 
can be between 30-100 amino acids in length and is subject to alternative splicing. The association 
domain is 135 amino acids in length and is responsible for the oligomerization of the holoenzyme 
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(Tombes et al., 2003). The formation of the holoenzyme brings catalytic heads into proximity, 
facilitating the unique ability of CaMK-II to autophosphorylate at site T287. CaMK-II is activated 
by the binding of Ca2+/CaM binding which relieves inhibition of the autoinhibitory arm, allowing 
for phosphorylation of site T287 (T286 in α). (Hudman and Schulman, 2002). The kinase is then 
capable of autophosphorylating the other subunits of the holoenzyme allowing for it to remain up 
to 80% activated after calcium stimulus has subsided (Tombes et al., 2003) (Rosenberg et al., 
2005).  
 CaMK-II is best known for its role in the central nervous system. It comprises over 1% of 
total protein in the brain, where it is a known regulator of neuronal plasticity and cognitive function 
(Bayer and Schulman, 2019). It is not only a key protein involved in long term potentiation, a 
process correlated to the formation of memories, but has recently been identified as a regulator of 
long term depression as well (Wang et al., 2013) (Hudman and Schulman, 2002) (Bayer and 
Schulman, 2019). Mice lacking αCaMK-II, the predominate form of CaMK-II in the brain, showed 
diminished long term potentiation in the hippocampus (Hinds et al., 1998). Conversely, mice that 
overexpressed activated CaMK-II had impaired context discrimination (Ye et al., 2019). These 
studies along with many others over the years have demonstrated the importance of CaMK-II in 
the brain.  
In addition to its roles in the brain, CaMK-II has also been shown to be present in almost 
every tissue and is involved in a large variety of processes throughout the body (Tombes et al., 
2003). CaMK-II is involved in Ca2+ regulation in the heart as well as heart morphogenesis (Maier 
and Bers, 2002) (Rothschild et al., 2009). It also has a role in regulating cell motility by inducing 
de-phosphorylation of focal adhesion proteins thereby promoting focal adhesion turnover. (Easley 
et al., 2008). CaMK-II is also involved in left-right asymmetry in vertebrates as well as the 
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development of neurons in the enteric nervous system (Langerbacher and Chen, 2008) 
(Francescatto et al., 2010) (Gao et al., 2012).   
 
CaMK-II as a PKD2 Target   
 Using zebrafish as a model organism, CaMK-II was determined to be required for kidney 
morphogenesis (Rothschild et al., 2011). CaMK-II is encoded by 7 genes in zebrafish (α, β1, β2, 
γ1, γ2, δ1, δ2) and is expressed throughout the embryo (Rothschild et al., 2011) (Rothschild et al., 
2009).  CaMK-II can be seen in the developing kidney beginning at 24hpf and is concentrated in 
the apical regions (Rothschild et al., 2011). Later, it can be seen throughout the pronephros at 
30hpf at apical and basolateral cell surfaces as well as in intracellular clusters (Rothschild et al., 
2011). Autophosphorylated CaMK-II is also present in the cloacal cilia at 30hpf (Rothschild et al., 
2011). Camk2g1 was shown to be the predominant form of CaMK-II present in the kidney 
(Rothschild et al., 2011).  
 Camk2g1 expression was suppressed in zebrafish embryos using a translation blocking 
antisense morpholino oligonucleotide (camk2g1 MO), causing defects in kidney development 
along with several other deformities (Rothschild et al., 2011). These defects include pronephric 
cyst development, hydrocephaly, loss of left-right asymmetry, and body curvature (Rothschild et 
al., 2011) (Francescatto et al., 2010). Inhibition of camk2g1 also caused a decrease in the distance 
kidney cells migrated during development (Rothschild et al., 2011). These cells were unable to 
undergo anterior convolution, preventing them from connecting with the glomerulus (Rothschild 
et al., 2011).This inhibition of kidney function was also demonstrated using a renal filtration assay 
showing a lack of fluid excretion over a 16 hour time period (Rothschild et al., 2011).  
 Inhibition of camk2g1 caused specific defects in the distal region of the pronephric ducts. 
Pronephric occlusions were seen in the distal portion at 3dpf in 73% of morphants embryos. In 
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addition, cloacal cilia formed normally in camk2g1 morphants at 24hpf, but by 48hpf they had 
begun to destabilize, causing a reduction the number of cloacal cilia present from 13 in wild type 
embryos to one in camk2g1 morphants. The remaining cloacal cilia present in morphant embryos 
were found to be shorter and immotile (Rothschild et al., 2011).  
A predominant defect seen in camk2g1 morphants was cyst development (Rothschild et 
al., 2011). This could be seen using both a camk2g1 morpholino and a dominant negative (DN) 
form of CaMK-II (K43A) which lacks phosphotransferase ability. These defects in kidney 
development, as well as other associated defects like body curvature and hydrocephaly, mimic the 
phenotype of zebrafish embryos with inhibited pkd2 expression (Mangos et al., 2010) 
(Schottenfeld et al., 2007) (Feng et al., 2008) (Rothschild et al., 2011). This led to the model that 
Ca2+ entry via pkd2 enables activation of CaMK-II which in turn influences kidney development 
by regulating cellular migration, pronephric convolution, and cloacal cilia stability (Rothschild et 
al., 2011). This model was supported by the co-injection of the morpholino for pkd2 and a 
constitutively active (CA) form of CaMK-II (T287D) which was able to rescue anterior migration 
and kidney convolution as well as reduce pronephric occlusions and hydrocephaly (Rothschild et 
al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
9 
 
Chapter 2: Calcium Signals Act through Histone Deacetylase to Mediate Pronephric  
Kidney Morphogenesis 
 
 
Abstract 
 
Autosomal dominant polycystic kidney disease (ADPKD) is the most common heritable disease 
the world, occurring in approximately 1-400 to 1-1000 live births. This disease, characterized by 
the development of large fluid filled cyst, is caused by mutations in genes PKD1 and PKD2. PKD2 
is a TRP cation channel necessary for Ca2+ entry and activation of CaMK-II, a serine/threonine 
protein kinase required for kidney morphogenesis and cilia stability. In an effort to further 
elucidate the molecular pathways involved during kidney morphogenesis as well as identify 
potential therapeutic targets for ADPKD patients, the role of class II HDACs present during kidney 
morphogenesis was evaluated as well as their relationship with camk2g1, the predominate form of 
CaMK-II present in the pronephros. Class II HDAC family members (HDAC4, 5, and 6) were 
suppressed using antisense morpholino oligonucleotides and pharmacological inhibitors. While 
inhibition of hdac6 caused no gross morphological defects, inhibition of hdac5 resulted in the 
development of anterior kidney cysts and destabilized cloacal cilia, mimicking the phenotype of 
both pkd2 and camk2g1 morphants. Inhibition of hdac4 caused elongated cloacal cilia when 
compared to control embryos. The reduction of hdac4 or hdac5 activity in camk2g1 morphants 
caused opposing results. Suppression of hdac4 in embryos with reduced camk2g1 activity rescued 
cilia shorting and ductal convolution defects while suppression of hdac5 caused severe branching 
of the pronephros and a significant loss of pronephric cell migration. Further investigation into the 
relationship between class II HDACs and CaMK-II revealed that inhibition of camk2g1 caused a 
translocation of hdac4 from the cytosol into the nucleus. The subcellular localization of hdac5 was 
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unaffected by the loss of camk2g1 activity. These results suggest a role for CaMK-II in retaining 
HDAC4 in the cytosol, enabling primary cilia formation and anterior kidney morphogenesis.  
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Introduction  
 
Histone Deacetylases 
Histone deacetylases (HDACs) are conserved enzymes that catalyze the removal of an 
acetyl group from lysine residues. This most commonly occurs on histones, where removal of the 
acetyl group condenses the chromatin structure, preventing transcription of target genes (Seto and 
Yoshida 2014). Histone deacetylases also have a variety of non-histone targets where they act to 
regulate a number of cellular processes. These processes include ubiquitination and degradation 
of p53, deacetylation of α-tubulin, and regulation of cell motility (Luo et al 2000) (Hubbert et al 
2002) (Di Giorgio et al 2013). The wide range of HDAC target was demonstrated using pan HDAC 
pharmacological inhibitors which caused in increase in acetylation in 10% of over 3500 tested 
acetylation sites (Choudhary et al 2009).  
Histone deacetylases are divided into four classes based upon sequence similarity. Class I 
HDACs include HDACs 1, 2, 3, and 8. Class II consists of HDACs 4, 5, 6, 7, 9, and 10. Class IV 
consists of HDAC11 (Seto and Yoshida, 2014). These three classes are all part of the 
arginase/deacetylase superfamily whose targets include both histone and non-histone proteins. 
Class III consists of NAD+ dependent proteins SIRT 1-7 and belongs to the Sir2 regulator family 
which is involved in transcription silencing (Seto and Yoshida, 2014) (Brachmann et al., 1995).  
Histone deacetylases are known to have roles in a variety a human diseases, making them 
an important candidate for therapeutic treatments (Seto and Yoshida, 2014). HDACs are associated 
with a variety of cancers and increased levels are associated with poor prognosis in ovarian and 
endometrial cancers (Li and Seto, 2016) (Weichert et al, 2008). In other types of cancers, such as 
melanoma and lung cancer, it is the loss of HDAC activity that is associated with poor prognosis. 
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(Li and Seto, 2016). Although their roles in various cancers may be complex, the use of selective 
and non-selective HDAC inhibitors have proven effective in the treatment of a number of cancers 
with over 20 pharmacological inhibitors being used in clinical trials (Li and Seto, 2016). HDAC 
inhibitors have also been successful in treating Alzheimer’s disease, where suppression of Hdac2 
resulted in increased synaptic plasticity and memory formation in mouse models (Graff et al., 
2012). HDACs have also been implicated in lung disease, cardiac abnormalities and a number of 
other disease making them an important topic of studies for treatment of human conditions (Seto 
and Yoshida 2014).  
Class II HDACs and CaMK-II  
 Class II HDACs regulate MEF2C gene transcription, genes that encode for Ca2+ dependent 
mediators of transcription (McKinsey et al, 2002). Interestingly, Mef2c knockout mice develop 
kidney cysts, mimicking the phenotype of both Pkd2 knockout mice and γ1 CaMK-II inhibited 
zebrafish (Xia et al., 2010) (Wu et al., 1998) (Rothschild et al., 2011). Interestingly, 
downregulation of HDACs in Pkd2 mutant mice have been able to inhibit cyst development (Xia 
et al, 2010). Two specific class II HDACs have a unique relationship with CaMK-II. HDAC4 
possesses a CaMK-II specific docking site allowing it be directly phosphorylated by CaMK-II. 
This causes its translocation from the nucleus to the cytosol in muscle tissue (Backs et al, 2006) 
(Little et al 2007).   
 CaMK-II is also able to affect the localization of HDAC5 through direct interaction with 
HDAC4 (McKinsey et al, 2002). While HDAC5 does not possess a specific binding site for 
CaMK-II, it is able to hetero-oligermerize with HDAC4 through their respective coil-coiled 
domains. This allows for HDAC5 to become responsive to CaMK-II in two different way. One 
being by bound to HDAC4 while it is interacting directly with CaMK-II. The second way by a 
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transphosphorylation event when interactions between HDAC4 bringing it into close proximity to 
CaMK-II (Backs et al., 2008). The ability of CaMK-II to directly affect the subcellular localization 
of specific class II HDACs combined with their previously studied role in kidney cyst development 
in mice demonstrate a potential role for class II HDACs in polycystic kidney disease pathology. 
Through the model organism zebrafish, this study further explains the roles of HDACs during 
kidney development as well as demonstrates interactions between class II HDACs and CaMK-II, 
a protein known to be affected in zebrafish ADPKD models (Rothschild et al, 2011).  
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Methods and Materials  
 
Zebrafish Strains and Care 
Zebrafish embryos were obtained though natural matings and raised at 28.5°C (Kimmel et al, 
1995). Zebrafish strains used were Wild-type (AB and WIK), Tg(atp1a1a.5:EGFP), and 
Tg(cmlc2:EGFP) 
 
Fluorescent Localization  
Embryos were fixed in 4% paraformaldeype or Dent’s fixative as previously described (Rothschild 
et al., 2011). Embryos were then incubated with one of the following primary antibodies: rabbit 
anti-acetylated histone H3 (Millipore [06-599] at 2.5 µg/ml), mouse anti‐acetylated α‐tubulin 
(Sigma Chemical Co. [T7451] at 2 μg/ml), or mouse anti‐α 1 Na+/K+‐ATPase (Developmental 
Studies Hybridoma Bank, University of Iowa [α6F] at a 1:10 dilution). Embryos were incubated 
overnight in primary antibody after which they were placed with one of the following secondary 
antibodies: goat anti‐mouse Alexa488 or goat anti‐rabbit Alexa568 (Invitrogen at 2.5 μg/ml). In order 
to analyze craniofacial development, embryos were incubated overnight at 4°C with rhodamine 
phalloidin (Life Technologies, 1:1000). Embryo heads were then dissected and mounted on 
chamber slides, and imaged using confocal microscopy. Embryos were imaged either on a Nikon 
E600 compound microscope using a 20X dry, 40X dry, or 100X oil immersion objective, or on 
Nikon AZ‐100 Macro Zoom fluorescent stereo microscope. 
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Morpholino Injections 
Translation-blocking antisense morpholinos were designed to target zebrafish camk2g1 (1ng), 
hdac4 (2ng), hdac5 (2ng), and hdac6 (8ng) and were purchased from Gene Tools along with a 
control mismatch morpholino (2ng). All morpholinos were used as previously described with an 
injection volume of 1nl (Francescatto et al., 2010) (Rothschild et al., 2011) (Rothschild et 
al., 2013). The morpholinos for hdac4, hdac5, and hdac6 were designed to target the following the 
regions around the translation start site: hdac4: CGCCACACTCACATCAACCATCAGC; 
nucleotides ‐11 to + 14), hdac5: GATCTTCCCTGCCTGAAGTTCTCCA; nucleotides ‐38 to ‐14), 
hdac6: TTTGGTATCTGGAACCGCATCCATC; nucleotides ‐5 to + 20) 
 
cDNA Injections 
Wild type zebrafish embryos were collected and RNA was extracted using TRIzol (Invitrogen) at 
1, 6, 19, 24, 48, and 72 hours post fertilization. cDNA was generated using SuperScript III. Hdac4 
(sense:5′-CCAAAGATGACTTCCCGCTCCGC-3′, antisense:5′-GAGGCTCTTGTTTAATGGT 
GACC-3′), hdac5 (sense:5′-GGAACACCACCCTCCTACAAACTCC-3′, antisense:5′GGAGG 
CTGTCTTGGAAGATCCGTCCC-3′), and hdac6 (sense:5′-CCGCTTTGACTGCACGCTA 
TGC-3′, antisense: 5′- CTAAGAGAGCTCCAGAAGGGGGCGTG-3′) were amplified using 
High Fidelity Taq (Invitrogen). Amplified products were then cloned into the StrataClone vector 
(Agilent), and sequenced as previously described (Rothschild et al., 2007). 
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Whole Mount In Situ Hybridization  
Digoxigenin‐labeled antisense riboprobes were synthesized as previously described using T3 or 
T7 RNA polymerase (Rothschild et al., 2007). Embryos used for whole‐mount in situ 
hybridization (WISH) were developed using alkaline phosphatase–conjugated anti‐
digoxigenin. Probes for Hdac4, hdac5, and hdac6 were designed to correspond to sequences 
amplified using the primer sets listed above. Cdh17, pax2a, and cmlc2 probes were prepared as 
previously described (Wingert et al., 2007; Wingert and Davidson, 2008). 
 
Mouse HDAC5 Expression Vector  
The murine hdac5 ORF was purchased from GE/Dharmacon (Clone ID: 5720438) and PCR‐
amplified using the following primers: Sense: 5′ GCGTCCGGAATGAACTCTCCCAACGAGT 
CGG 3′; Antisense: 5′ CGCTCTAGAGGGATGGGGGCCAGGGTGTCACAG 3′.  It was then 
digested with BspEI and XbaI, and cloned into the pEGFP‐C1 vector with N‐terminal EGFP. 
This hdac5 construct was injected at the one cell stage into zebrafish embryos at a concentration 
of 30 ng/µl. The murine hdac4 was a gift from Dr. Eric N. Olson and was injected at 30 ng/μl at 
the one cell stage (Backs et al., 2006). HDAC4 and HDAC5 localization was assessed in live 
embryos at 24–48 hpf. 
 
Zebrafish HDAC4 Expression Vector and mRNA Synthesis  
Zebrafish HDAC4 was PCR-amplified (CGCGGATCCCATGACTTCCCACAGCCGTCCAG, 
GCGCTCGAGGATGGAGAGATTAGAGGGACATCAG) from 24hpf cDNA and cloned into 
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the pCRII-TOPO vector (Invitrogen). HDAC4 was cloned into the Gateway middle entry vector 
using BamHI and Xhol. Cherry was amplified (CCAAGCTTATGGTGAGCAAGGGCGAGGA 
GG, GGATCCCGCGCTTGTACAGCTCGTCCATGCC), digested with HindIII and BamHI, and 
ligated into HDAC4 entry vector. This vector was cloned into the final Gateway vector with the 
5’ Sp6 pEntry vector and 3’ poly A entry vector. The construct was linearized using SpeI and 
mRNA was generated using the Sp6 mMessage kit (Thermo) 
 
HDAC Rescue 
Hdac4 MO (2ng) and hdac4 RNA (100ng) were co-injected or sequentially injected into zebrafish 
embryos at the one cell stage. Embryos were assessed at 24hpf to assess left-right asymmetry. 
Embryos were fixed at 72hpf, labeled with mouse anti-acetylated α-tubulin in order to assess cilia 
length and number, and imaged using confocal microscopy. 
Hdac4 MO (2ng) was injected into zebrafish embryos at the one cell stage alone or co-injected 
with mouse EGFP-HDAC5 (30ng/µl). Left-right asymmetry was assessed at 24hpf. At 72hpf, 
embryos were fixed and labeled with mouse anti-α1 Na+/K+-ATPase. Embryos were then 
analyzed for ductal convolution and anterior cell migration using confocal microscopy. 
 
Drug Treatment  
Zebrafish embryos were incubated in 0–200 nM TSA or 0–10 μM tubastatin A in 3 ml of system 
water starting at cleavage stage and continuing until fixing. Rescue experiments were performed 
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by continuously incubating camk2g1 morphants embryos with 100 nM TSA beginning at bud stage 
until being fixed. 
 
Generation of Nuclear and Cytosolic Targeted HDAC Constructs 
Point mutations were generated on the previously used EGFP-HDAC5 and Cherry-HDAC4 
expression constructs using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies 
#200519). The mutated sites for HDAC4 were S458A, S606A, S458D, and S606E. The mutated 
sites for HDAC5 were S251A, S480A, S251D, and S480D.   The construct was sequenced to 
confirm the mutation was achieved as well as to confirm no additional mutations were present. 
Products were then purified and transformed as previous described (Rothschild et al, 2011).  
 
Video Microscopy  
Live embryo cilia videos were obtained using DIC optics on a Nikon 60X water‐immersion Plan 
APO objective and 20‐frames‐per‐second acquisitions. Embryos were anesthetized and 
immobilized as previously described (Rothschild et al., 2011). 
 
Statistical Analysis  
Statistical significance was set at P<0.005 using the two-tailed t-test  
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Results 
 
Expression of Class II HDAC 4, 5, and 6 are Detected in Zebrafish Embryos 
Throughout Early Development 
Three Class II HDACs were evaluated for their effects on early development based upon 
their previously established roles in relation to CaMK-II and kidney development. HDAC4 is 
known to be CaMK-II responsive in muscle tissue as well as possess a specific CaMK-II docking 
site (Di Giorgio and Brancolini, 2016). HDAC5 has also been shown to be responsive to CaMK-
II, however only in the presence of HDAC4 (Backs et al., 2008). In contrast to other HDACs, 
HDAC6 deacetylates tubulin over histones and suppression of HDAC6 caused a reduction in cyst 
formation in mouse models of cystic kidney disease (Cebotaru et al., 2016; Li et al., 2016; Yanda 
et al., 2017a; Yanda et al., 2017b).  
Expression of hdac4, hdac5, and hdac6 can be seen using both semiquantitative reverse 
transcription-polymerase chain reaction (RT-PCR) as well as in situ hybridization (Figure 2.1 U-
Z). Transcript levels for all three genes were seen throughout development, from maternal 
transcripts through to 72hpf. All three transcripts were also able to be amplified from isolated 
kidneys at 24hpf. Hdac4 and hdac6 mRNA were also able to be amplified from isolated heart 
tissue at 36 hpf (Figure 2.1 U-W).  
 
Inhibition of Specific Class II HDACs Causes Defects in Early Development  
In order to evaluate the roles of HDAC4, HDAC5, and HDAC6 in early development, 
translation blocking antisense morpholinos were designed for each, and injected into zebrafish 
embryos at the 1-4 cell stage. Tail curvature defects can been seen in all three morphants at 24 hpf 
when compared to control embryos (Figure 2.1 A-D). These defects were persistent and could be 
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seen at 48hpf and 72hpf in all three morphants (Figure 2.1 E-L). Previous studies indicated a role 
for hdac4 in craniofacial development in zebrafish embryos. Similarly, craniofacial defects, 
including clefting were observed in hdac4 morphants at 72hpf, consisted with previously published 
data (DeLaurier et al., 2012) (Figure 2.1 M,N). 
The effectiveness of the hdac4 and hdac5 morpholinos were assessed by examining the 
levels of acetylated histone 3 in morphant embryos at 48hpf. Acetylated histone 3 levels were 
elevated in morphants when compared to controls demonstrating a decrease in levels of hdac4 and 
hdac5 activity. The effectiveness of the hdac6 morpholino was examined by observing acetylation 
levels in α-tubulin in lateral line axons and in the brain in hdac6 morphants and control embryos. 
Hdac6 morphants show an increase in acetylation levels in α-tubulin when compared to control 
embryos demonstrating a decrease in hdac6 levels in morphants embryos (Figure 2.1 O-T ) 
At 48hpf, hdac4 and hdac6 morphants exhibited no defects in kidney morphology. 
However, hdac5 morphants exhibited kidney cyst in the anterior portion of the pronephric ducts 
near the glomerulus (Figure 2.2 A-D). This mimics cyst development seen in both camk2g1 
morphants and pkd2 morphants (Rothschild et al., 2011). This cyst development could be 
associated with lack of ductal convolution in these embryos. Ductal convolution is the turning 
inward of the two pronephric ducts in order to connect with the glomerulus. When ductal 
convolution was assessed in all three morphants, there was an absence of convolution in 80% of 
hdac5 morphants. In contrast, only 15% of hdac4 morphants and 3% of hdac6 morphants failed to 
convolution (Figure 2.2 E-M, p<.005). This lack of convolution could be caused by a decrease in 
the distance pronephric cells migrate during development. This distance of cell migration can be 
examined by measuring the distance from the base of the ear and the top of the kidney at 72hpf 
(Rothschild et al, 2011). Compared to control embryos, the distance between the ear and the kidney 
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was significantly increased in hdac5 morphants and unchanged in hdac4 and hdac6 morphants 
(Figure 2.2 N, p<.005).  
Inhibition of Class II HDACs Disrupts Primary Cloacal Cilia  
 Cilia are present in the zebrafish pronephros in both the ducts and the cloaca. Ductal cilia 
are approximately 9µm in length and are derived from both mono- and multi-cilia. Cloacal cilia 
are primary cilia that are shorter at approximately 3µm in length and rotate (Kramer‐Zucker et 
al., 2005) (Sarmah et al., 2007) (Rothschild et al., 2011). In both pkd2 and camk2g1 morphants, 
cloacal cilia is disrupted while ductal cilia is unaffected (Rothschild et al, 2011). In hdac5 
morphants, cloacal cilia is disassembled at 72hpf. Any remaining cloacal cilia in hdac5 morphants 
were immotile and much shorter in length. Cloacal cilia were also affected in hdac4 morphants 
though in an opposite way. Cloacal cilia were still able to rotate but were elongated to an average 
length of 5µm in hdac4 morphants (Figure 2.3 A-F, p<.005). The length of cloacal cilia in hdac4 
morphants could be rescued by a co-injection of the hdac4 morpholino and 100ng of cherry-hdac4 
mRNA (Figure 2.3 F, p<.005). In order to assure that these defects were not caused by a lack of 
specification of kidney cells, expression of cdh17 and pax2 (two early kidney markers) was 
assessed and found to be normal in all morphants embryos (data not shown). Interestingly, no 
defects were seen in cloacal or ductal cilia in hdac6 morphants (Figure 2.3 A-F).  
 Primary cilia were also shown to be disrupted in the organ of asymmetry in pkd2 and 
camk2g1 morphants. The primary cilia in the organ of asymmetry, known was the Kupffer’s 
vesicle (KV), get resorbed when PKD2 or CaMK-II is inhibited (Francescatto et al 2010). In order 
to assess whether the KV was also affected in class II hdac morphants, cardiac asymmetry was 
examined using cmlc2. In both hdac4 and hdac5 morphants cardiac asymmetry was lost at 24hpf. 
However, it was unaffected in hdac6 morphants. This loss of asymmetry in hdac4 morphants could 
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be recovered by co-injection of cherry-hdac4 mRNA and it could be partially recovered in hdac5 
morphants by co-injection of mouse EGFP-HDAC5 (Figure 2.3 G-J). Primary cilia in the KV was 
similarly disrupted as cloacal cilia in the hdac morphants. Hdac4 morphants showed slightly longer 
cilia in the KV, while hdac5 morphants exhibited shorter cilia (Figure 2.3 K-N).  
 
HDAC Inhibitors Cause Defects in Kidney Development Similar to HDAC Morphants 
 TSA is a pan HDAC inhibitor that is known to be effective at inhibiting class I, II, and IV 
HDACs in zebrafish  (Cao et al., 2009b; Bertrand, 2010; de Groh et al., 2010). Zebrafish embryos 
treated with up to 200nM of TSA were viable and showed no defects in gross morphology. 
However, both ductal convolution and kidney cell migration were both negatively affected with 
TSA treatment similar to hdac5 morphants (Figure 2.4 E,F, p<.005). Embryos treated with TSA 
also displayed a loss of left-right asymmetry and cloacal cilia were elongated in a similar manner 
as hdac4 morphants (Figure 2.4 A-D). Embryos treated with tubastatin A and tubacin, a HDAC6-
specific inhibitor, showed no defects in left-right asymmetry or kidney morphogenesis, again 
mimicking the phenotype of hdac6 morphants (Butler et al., 2010) (Figure 2.4 D-F).  
 
Inhibition of HDAC4 in camk2g1 Morphants Partially Rescues Ductal Convolution  
 Epistatic interactions between CaMK-II and Class II HDACs were evaluated by co-
injection of camk2g1 morpholino and either hdac4, hdac5, or hdac6 to evaluate whether the 
phenotypic defects seen in camk2g1 morphants was exacerbated or rescued. Ductal convolution is 
lost in embryos with inhibited camk2g1. However, suppression of hdac4 in camk2g1 morphants 
partially restored ductal convolution. This was also seen with treatment of TSA (Figure 2.5 A-P). 
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Interestingly, suppression of hdac5 in camk2g1 morphants exacerbated the morphants phenotype, 
causing branching of the pronephric ducts. This branching is similar to what was observed when 
embryos were injected with a kidney targeted dominant negative CaMK-II (Figure 2.5 A-P) 
(Rothschild et al, 2011). It is of note that although co-injection of hdac4 MO and camk2g1 MO 
partially rescued ductal convolution, cell migration was not rescued, indicated by an increase in 
ear-kidney distance when compared to control embryos (Figure 2.5 Q). This suggest separate 
mechanisms mediate ductal convolution and cell migration during kidney morphogenesis.  
 
Suppression of HDAC4 in Camk2g1 Morphants Prevents Cilia Disassembly 
 Epistatic interaction between camk2g1 and class II HDACs were further evaluated by 
assessing the effects of suppressed hdac4 and hdac5 on the cloacal cilia of camk2g1 morphants. 
Inhibition of camk2g1 in zebrafish embryos causes disassembly of cloacal cilia (Rothschild et al. 
2011).  Suppression of hdac4 in camk2g1 morphants was able to prevent cilia disassembly in the 
cloaca, increasing the average number of cloacal cilia from 1 to an average of 8 (Figure 2.6 A-F, 
p<.005). The cloacal cilia in embryos co-injected with hdac4 MO and camk2g1 MO were similar 
in length to control embryos (3µm) and fully functional (Figure 2.6 G, p<.005). These results were 
also mimicked with TSA treatment (Figure 2.6 E-G, p<.005). Co-injection of hdac5 MO and 
camk2g1 MO did not rescue cloacal cilia as the average number present in co-injected embryos 
was 1 (Figure 2.6 A-F, p<.005). The remaining cilia that were present were shorter in length as 
previously seen in camk2g1 morphants (Figure 2.6 G, p<.005).  
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Subcellular Localization of HDAC4 is altered with CaMK-II Inhibition  
CaMK-II is known to directly influence the subcellular localization of HDAC4 in muscle tissue as 
well as influence the localization of HDAC5 in the presence of HDAC4 (Backs et al., 2006). To 
determine how suppression of CaMK-II influences localization of HDAC4 and HDAC5, EGFP-
tagged HDAC4 and HDAC5 constructs were injected with and without the camk2g1 MO. Muscle 
cells expressing the EGFP-tagged HDAC4 or HDAC5 show predominantly nuclear expression, 
which remain unchanged with suppression of camk2g1 (Figure 2.7 A,B,E,F). This was the same 
for pronephric cells expressing EGFP-tagged HDAC5, with expression being predominantly 
nuclear with and without the presence of the camk2g1 MO (Figure 2.7 C,D). However, localization 
of HDAC4 in pronephric cells was altered with suppression of camk2g1. Suppression of camk2g1 
caused a shift in EGFP-HDAC4 localization from predominately nuclear to cytosolic. This suggest 
a specific role of CaMK-II to retain HDAC4 in the cytosol during kidney morphogenesis (Figure 
2.7 G,H).  
 
Assessing the Effects of Nuclear and Cytosolic Targeted HDAC4 and HDAC5 Expression 
Constructs 
 In muscle tissue, HDAC4 is CaMK-II responsive due to a specific docking domain and 
two CaMK-II phosphorylation sites at sites S467 and S632 (sites S458 and S606 in zebrafish). 
Phosphorylation at these sites causes translocation from the nucleus to the cytosol. HDAC5 is 
CaMK-II responsive in the presence of HDAC4 through the use of its phosphorylation sites at 
S259 and S498 (sites S251 and S480 in zebrafish) (Backs et al, 2008). Previous results show that 
CaMK-II affects localization of HDAC4 in pronephric cells as well. In order to determine whether 
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phosphorylation at these sites is necessary for correct localization in pronephric cells, four kidney 
targeted constructs were generated that localize HDAC4 and HDAC5 either to the nuclear or to 
the cytosol. The nuclear targeted constructs were generated by causing a point mutation at the 
CaMK-II responsive sites changing the serine to an alanine, thereby inhibiting phosphorylation. 
The cytosolic targeting constructs were made by changing the serine to either an aspartic acid or a 
Glutamic Acid, which mimics phosphorylation at these sites and should localize it to the cytosol. 
Preliminary studies with these constructs analyzed ductal convolution in injected embryos. This 
resulted in a loss of convolution in 50% of nuclear targeted HDAC4 injected embryos, while 
embryos expressing cytosolic HDAC5 remained unaffected (Figure 2.8) (Figure 2.9).  
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Discussion  
  
This study aimed to investigate the link between calcium signaling and epigenetic 
regulation by histone deacetylases during kidney morphogenesis. It also provides new insight into 
potential therapeutic targets for autosomal dominant polycystic kidney disease (ADPKD) patients. 
Calcium is a necessary signaling component for kidney morphogenesis, with Ca2+ flux during 
development occurring in part through the cation channel encoded for by the gene PKD2, a gene 
whose mutation is known to cause the development of polycystic kidney disease (Igarishi and 
Somlo, 2002) (He et al, 2011). In zebrafish models of ADPKD, loss of calcium signaling through 
mutations in pkd2 cause a decrease in the activity of Ca2+/calmodulin dependent protein kinase 2 
(CaMK-II) (Rothschild et al, 2011). Loss of CaMK-II activity causes defects similar to pkd2 
morphants including the development of anterior pronephric cysts, loss of cell migration and ductal 
convolution in the pronephros, as well as defects in left-right asymmetry, hydrocephaly, and 
dorsal-axis curvature (Rothschild et al, 2011). Although CaMK-II is known to be necessary for 
kidney morphogenesis, the downstream targets of CaMK-II activity in the pronephros have yet to 
be elucidated.  
Associations between CaMK-II and Class II HDACs have been reported in cardiac tissue 
(Backs et al, 2008). In cardiac tissue, HDAC4 is directly phosphorylated at sites S467 and S632 
by CaMK-II inducing the binding of chaperone proteins and sequestration in the cytosol (Backs et 
al, 2008).  This study is the first to demonstrate that CaMK-II has a similar effect on HDAC4 in 
pronephric cells during kidney morphogenesis. Suppression of camk2g1 caused translocation of 
HDAC4 into the nucleus thereby preventing transcription of its target genes. Autonomous CaMK-
II is present in both the anterior and posterior pronephric duct and loss of activity causes specific 
defects in those regions (Rothschild et al, 2011). Therefore, it is likely that the sequestration of 
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HDAC4 in the cytosol enables transcription of specific target genes for the anterior and posterior 
pronephros.  
Anterior pronephric defects caused by inhibition of camk2g1 activity include loss of 
cellular migration and ductal convolution (Rothschild et al, 2011). CaMK-II has previously been 
associated with focal adhesions turnover in cell culture. Suppression of CaMK-II activity caused 
an increase in the size of focal adhesion complexes and a decrease in cell motility (Easley et al, 
2008). In contrast, constitutively active CaMK-II caused a loss of phospho-tyrosine levels in focal 
adhesion kinase (FAK) and paxillin causing a reduction in the size of focal adhesion complexes 
and a decrease in cell motility (Easley et al, 2008). As cell motility and convolution defects are 
seen in the pronephric ducts of camk2g1 morphants and convolution defects are rescued with 
hdac4 inhibition, it is possible that targets of hdac4 include genes that promote focal adhesion 
turnover, enabling ductal convolution to take place. However, these results also suggest that 
pronephric cell migration and convolution involves several pathways, as convolution was rescued 
in camk2g1 morphants with hdac4 suppression but the pronephric cells still were unable to 
migration to their normal anterior position. 
Posterior defects in camk2g1 morphants include loss of cloacal cilia development and 
stability. Inhibition of hdac4 caused elongation of cloacal cilia suggesting that targets of hdac4 
promote primary cilia formation in the cloaca. This could occur through transcription of a gene 
called missing in metastasis (MIM). This gene has been previously identified as being required in 
the basal bodies for cilia maintenance (Bershteyn et al., 2010). This gene is also known to be a 
target of MEF2C, which has previously been established to be regulated by HDAC4 (Saarikangas 
et al, 2011). This suggest that a possible mechanism could be that sequestration of hdac4 in the 
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cytosol by camk2g1 enables meft2c gene transcription in the posterior kidney, which in turn 
promotes cilia formation through transcription of mim.  
In mouse and zebrafish models, suppression of HDAC through pharmacological inhibition 
reduced cyst formation in pkd2 mutant and morphants (Cao et al, 2009) (Xia et al, 2010). Similar 
results were produced with the use of the pan-HDAC inhibitor TSA, where treatment was able to 
prevent cyst formation in camk2g1 morphants as well as rescue ductal convolution, ciliary length, 
and cell migration. Although our results show that both hdac4 and hdac5 play roles during kidney 
morphogenesis, our results suggest that TSA acts to rescue kidney development primarily though 
inhibition of hdac4.  
Previous research has shown that HDAC5 can be responsive to HDAC4 in the presence of 
CaMK-II (Backs et al, 2008). However, unlike HDAC4, HDAC5 does not possess a specific 
CaMK-II docking site, and it is only responsive through interactions with HDAC4. Loss of hdac5 
activity resulted in defects in ductal convolution and cell migration as well as caused the 
development of kidney cysts (Backs et al, 2008). In contrast to hdac4, suppression of hdac5 was 
not able to rescue ductal convolution or cell migration in camk2g1 morphants. In fact, defects were 
exacerbated with branching of the pronephric ducts occurring. This suggest that although both 
camk2g1 and hdac5 influence kidney morphogenesis, they work in separate pathways. This was 
also supported by camk2g1 inability to affect the localization of hdac5.  
Results from this study lead to the following proposed model of action. During normal 
development, calcium flux though the cation channel PKD2 enables activation of CaMK-II. 
CaMK-II is then able to become autonomous and interact with HDAC4, retaining it the cytosol 
allowing for transcription of its target genes. In camk2g1 inhibited embryos, HDAC4 is unable to 
be retained in the cytosol, so it translocates to the nucleus, where it inhibits transcription of genes 
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necessary for development (Figure 2.10). Future studies will include the use of kidney targeted 
HDAC4 and HDAC5 constructs that should localize to either the nucleus or the cytosol in order 
to further validate this model. The inactive HDAC4 and HDAC5 constructs have a mutation 
preventing phosphorylation known CaMK-II phosphorylation sites. Based upon our model, this 
mutation should cause HDAC4 to localize to the nucleus as it is unable to be phosphorylated by 
CaMK-II. The cytosolic targeted HDAC4 contained a phosphomemetic mutation the two known 
CaMK-II phosphorylation sites which should cause its retention in the cytosol. Based upon 
previous research, it is expected that the same mutations will cause nuclear or cytosolic localization 
in the HDAC5 construct as well. However, these two sites are CaMK-II responsive sites. As this 
data suggest that CaMK-II and HDAC5 are working in separate pathways to affect kidney 
morphogenesis, it is possible that it is phosphorylation at other sites that affect HDAC5 activity 
during development.  
This study newly identifies HDAC4 as a target of CaMK-II during kidney morphogenesis. 
It also provides a potential area of interest for new therapeutic targets for ADPKD. However, this 
study also demonstrates that specific pharmacological inhibitors may be necessary when designing 
treatments for ADPKD. Although inhibition of hdac4 was able to rescue convolution in camk2g1 
morphants, those defects were exacerbated by inhibition of hdac5. Based on these results, 
investigators should aim for more specific methods of treatment as these two proteins appear to 
have opposing effects on kidney development.  
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Figure 2.1 Morphology of class II hdac morphants: Embryos were injected with 2ng of control, 
2ng of hdac4, 2ng of hdac5, or 8ng of hdac6 MO. Gross morphology was assessed at 24hpf, 48hpf, 
and 72hpf (A-L). Scale bar = 500 µm. HDAC4 morphants showed orofacial defects including 
partial cleft (N) compared to control embryos (M) at 72hpf. Scale bar = 100µm. Acetylated histone 
H3 levels were assessed at 48hpf in control embryos (O,Q), 2ng hdac4 MO (P), or 2ng hdac5 MO 
(R). Scale bar = 5µm. Acetylated α-tubulin was assessed in control (S) and 8ng hdac6 MO (T) 
embryos. Scale bar = 500µm. Semiquantitative RT-PCR reaction analyzed the expression of class 
II HDACs during development (U-W). Expression was also assessed using whole-mount in situ 
hybridization at the one cell stage and 48hpf (X, Y, Z).  
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Figure 2.2 Kidney cysts are visible in hdac5 morphants. Dorsal views of 48hpf embryos 
injected with 2ng control, 2ng hdac4, 2ng of hdac5, or 8ng of hdac6 MO (A-D). Kidney cysts are 
visible in hdac5 morphants (C). Class II HDAC morphants were immunostained for α1 
Na+K+ ATPase at 72hpf and imaged at low magnification (E-H) and high magnification (I-L). 
Scale bar = 100µm. Hdac5 morphant embryos show of loss of ductal convolution (M) and loss of 
anterior migration (N). n=40-70 embryos per experiment. *P < 0.005. 
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Figure 2.3. Inhibition of hdac4 and hdac5 cause opposing effects on primary cilia. Lateral 
views of primary cilia in the junction of a pronephric duct with the cloaca in 72hpf embryos 
immunostained for acetylated tubulin (A-D). Scale bar = 5 μm. Length and number of cloacal cilia 
were assessed at 72hpf and compared to controls (E,F). n = 15–30 embryos. *P < 0.005. Cardiac 
asymmetry was analyzed by cmlc2 expression at 24 hpf (G–I) and plotted as a percentage of 
embryos (J). n = 20–38 embryos. Primary cilia length in the KV at the 12‐somite stage (K–M) is 
averaged (N). n = 40–60 cilia. Scale bar = 5 μm. *P < 0.005. 
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Figure 2.4. Pharmacological inhibition of class II HDACs mimic morphant phenotype. 
Embryos were treated with 0-200nM trichostatin A or 10μM tubastatin A beginning at the cleavage 
state. Cloacal cilia were imaged at 72hpf (A,B) and averaged (C). Scale bar = 5μm. n = 15–30 
embryos. Cardiac asymmetry was assessed at 30hpf (D). n = 30–40 embryos. Anterior kidney 
convolution (E) and kidney ear distance (F) were determined at 72hpf. n = 15–26 embryos. 
*P < 0.005. 
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Figure 2.5. CaMK-II and HDACs work in the same molecular pathway enabling anterior 
kidney morphogenesis. Embryos were injected with camk2g1 MO (1 ng), hdac4 MO 
(2 ng), hdac5 MO (2 ng), camk2g1 and hdac MOs together, or the camk2g1 MO followed by bud‐
stage trichostatin A treatment. Embryos were laterally imaged at 72hpf using DIC optics (A–E) or 
imaged dorsally using immunofluorescence of α1 Na+/K+ATPase (F–O). Scale bars = 100μm. 
Arrowheads in I and N indicate adventitious lumens, and arrows indicate branched ducts. 
Convolution was assessed at 72hpf (P) and pronephric migration was assessed by posterior ear‐
anterior kidney distance in μm at 72hpf (Q). n = 30–41 embryos. 
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Figure 2.6. CaMK-II and HDACs work in the same molecular pathway leading to cloacal 
cilia development and stabilization. Embryos were injected with the camk2g1 MO (CaMKII; 
2 ng), hdac 4 MO (2 ng), hdac5 MO (2 ng), camk2g1 and hdac MOs together, or 
the camk2g1 MO followed by bud‐stage trichostatin A treatment. Embryos were imaged at 72 hpf 
after immunolabeling with acetylated tubulin (A–E, green). Scale bar = 5 μm. Cilia number and 
length were assessed at 72 hpf and compared to control embryos and camk2g1 morphants (F,G). 
*P < 0.005 compared to control embryos. **P < 0.005. N = 25–62 cilia. 
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Figure 2.7. HDAC4 subcellular localization is altered with inhibition of camk2g1. Embryos 
were injected with EGFP‐HDAC5 (30 ng/μl) alone (A,C), EGFP HDAC5 and camk2g1 MO (1 ng) 
(B,D), EGFP‐HDAC4 (30 ng/μl) alone (E,G), and EGFP‐HDAC4 and camk2g1 MO (1ng) (F,H). 
Embryos were analyzed for subcellular localization in muscle cells (A,B,E,F) and kidney cells 
(C,D,G,H) at 24hpf and 48hpf. n = 15–20 embryos. Scale bar = 5μm. 
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Figure 2.8. Ductal convolution in nuclear targeted HDAC4 embryos. Anterior convolution was 
assessed in embryos injected at the 1-4 cell stage with 30ng of Cherry-HDAC4 S488A S606A. 
Convolution was observed by immunostaining the kidney specific NaKATPase. Ductal 
convolution was varied in HDAC4 S488A S606A embryos with half having ductal convolution (A) 
and half lacking ductal convolution (B). N=4.  
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Figure 2.9: Ductal convolution in cytosolic targeted HDAC5 embryos. Anterior convolution 
was assessed in embryos injected at the 1-2 cell stage with 30ng of EGFP-HDAC5 S251A S480A. 
Convolution was observed by immunostaining the kidney specific NaKATPase. Convolution was 
observed in control embryos (A, n=2) as well as in HDAC5 S251A S480A embryos (B, n=2) 
 
 
 
 
 
 
39 
 
 
 
Figure 2.10. Model of action. Ca2+ flux through PKD2 activates CaMK‐II to sequester HDAC4 
in the cytosol. Sequestration of HDAC4 in the cytosol reduces allows for relaxation of the 
chromatin and transcription of HDAC4‐target genes. Loss of PKD2 or CaMK‐II induced the 
release of HDAC4 translocate to which then translocated to the nucleus to inhibit target expression. 
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Chapter 3: Investigations into the Role of CaMK-II in Kidney Cell Migration                                                                         
 
Abstract  
 
The serine/threonine protein kinase CaMK-II is known to play several roles during zebrafish 
kidney development. These include ciliary stability, pronephric migration, and pronephric 
convolution, although the exact mechanisms of these actions are currently unknown. This study 
aims to further understand these pathways by investigating three potential mechanisms for CaMK-
IIs involvement in kidney development. In this study, camk2g1 morphants had decreased rates of 
kidney cell migration when compared to controls, causing a decrease in the distance traveled by 
migrating cells. Previous research has shown that loss of CaMK-II activity increases the size of 
focal adhesion complexes resulting in decreased migratory capabilities. In addition, alterations in 
expression of the extracellular matrix protein collagen is caused by loss of pkd2, a cation channel 
necessary for CaMK-II activity. As interactions between migrating cells and the ECM are 
necessary for focal adhesion formation and turnover, alterations in collagen expression was 
assessed in camk2g1 morphants as a possible cause for the decreased rate of migration.  
Suppression of camk2g1 caused increases in col2a1a present in the notochord. Suppression of 
collagen secretion using the secretory inhibitor Brefeldin A was able to partially rescue pronephric 
convolution in morphants embryos. The decreased rate of migration in camk2g1 morphants could 
also be caused by loss of notch signaling. Notch signaling is necessary for cell differentiation in 
the zebrafish kidney and loss of notch signaling is associated with a loss of cellular migration in 
drosophila. Inhibition of camk2g1 caused alterations in notch signaling proteins in the cloaca 
which could be restored with inhibition of HDAC4, indicating that notch signaling proteins may 
be downstream of CaMK-II and HDAC4 activity during kidney morphogenesis. This study 
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contributes to the understanding of the various roles of CaMK-II during kidney morphogenesis. 
Although it is likely that the effects of camk2g1 inhibition seen is this study is the result of several 
developmental pathways being affected, it is possible that CaMK-II regulation of the subcellular 
localization of HDAC4 directly or indirectly regulates notch signaling pathways, which in turn 
affects collagen expression and cellular migration. Further studies will be necessary to understand 
the potential connections between these pathways.  
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Introduction 
 
Autosomal dominant polycystic kidney disease is one of the most common heritable 
disease in the world (Igarishi and Somlo, 2002). It is also a disease that in spite of its prevalence, 
little treatment options exists. Treatment for this disease currently consist of lifestyle changes such 
as a healthier diet and exercise, and medication to alleviate the symptom from the kidney’s reduced 
function, such as medications for blood pressure (Helal, 2015). The lack of treatments for this 
disease is due partially to gaps in understanding about disease progression. Mutations in genes 
PKD1 and PKD2 are known to be the primary causes of ADPKD, with reduced calcium signaling 
occurring due to these mutation (Igarishi and Somlo, 2002).  
Research occurring within the past 10 years has identified CaMK-II as a downstream 
effector of the cation channel PKD2 (Rothschild et al, 2011). In zebrafish models, inhibition of 
camk2g1, the predominant form of CaMK-II present in the kidney, causes a loss of cell migration, 
loss of ductal convolution, and destabilization of cloacal cilia. In addition, zebrafish with inhibited 
camk2g1 also display dorsal axis curvature and develope anterior kidney cyst, mimicking zebrafish 
pkd2 morphants (Rothschild et al, 2011) (Mangos et al., 2010) (Obara et al., 2006) (Schottenfeld 
et al., 2007). Histone deacetylase 4 (HDAC4) is also affected by a reduction in camk2g1 activity. 
Suppression of CaMK-II causes translocation of HDAC4 from its normal location in the cytosol 
to the nucleus, thereby inhibiting its target genes (Rothschild et al, 2018). Co-inhibition of CaMK-
II and HDAC4 is able to recue ductal convolution in camk2g1 morphants, leading to the model in 
which CaMK-II works to retain HDAC4 in the cytosol allowing for transcription of its target genes, 
thereby promoting kidney development (Rothschild et al, 2018).  
In order to develop effective therapeutic techniques for ADPKD patients, this study aims 
to further understand how CaMK-II influences kidney development by investigating its roles in 
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cellular migration during morphogenesis. Inhibition of CaMK-II is known to cause a loss of kidney 
cell migration, but specifically how suppression of CaMK-II activity affects migration is currently 
unknown. One possibility, is that CaMK-II affects the rate of cell migration during development. 
During kidney morphogenesis, specified pronephric cells undergo epithelialization at 
approximately 18hpf before migrating anteriorly where they undergo ductal convolution in order 
to connect with the glomerulus (Drummond and Davidson, 2010). Kidney cells maintain specific 
rates of migration at distinct periods of development. Prior to 24hpf, kidney cells migrate slowly, 
at a rate of approximately 2µm/hour. Beginning at 28.5hpf and continuing until 3dpf, this rate 
increases to 6µm/hour (Vasilyev et al, 2009). This increase in rate corresponds to cell proliferation 
in the distal segment of the pronephric kidney and the start of active fluid transport into the 
pronephric lumen (Vasilyev et al, 2009). Embryos with downregulated CaMK-II exhibit a 
dramatic decrease in anterior migration, as measured by the distance between the back of the ear 
and the top of the kidney, at 72hpf (Rothschild, et al, 2011).Therefore, it is possible that inhibition 
of CaMK-II is affecting the rate at which specified kidney cells migrate, thereby preventing 
connection with the glomerulus and kidney function.  
 If CaMK-II is affecting the rate at which kidney cells migrate during development, then it 
is important to understand specifically what is slowing migrating cells. During development, 
kidney cells migrate via collective cell migration. Collective cell migration is reliant upon the 
formation of focal adhesion complexes that form when the extracellular matrix proteins interact 
with integrin receptors in motile cells (Easley et al, 2008). Alteration in extracellular matrix 
components have long been associated with cyst development. Human ADPKD cells exhibit an 
overproduction of extracellular matrix components when compared to normal cells (Wilson et al, 
1992). These cells also have decreased migratory capabilities due to their increased adhesiveness 
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to the extracellular matrix component collagen (Drummond, 2011). Alterations in ECM proteins 
have also been seen in animal models of ADPKD. In mouse models, kidney cyst development is 
associates with irregular expression of several ECM proteins including collagen and laminin 
(Ebihara et al, 1995).  
Zebrafish models for ADPKD exhibit similar alterations in ECM components. Body 
curvature is a consistent phenotype seen in morphants for both pkd2 and camk2g1 (Schottenfeld 
et al, 2007) (Rothschild et al, 2011). This body curvature is associated with an increased amount 
of type II collagen present in the notochord sheath (Mangos et al, 2010). Zebrafish pkd2 morphants 
also have an increased expression of col2a1, col9a2, and col27al in the notochord due to alterations 
in post translational modification (Mangos et al, 2010) (Le Corre et al, 2014). This increase is 
associated with an increase in COPII secretory proteins, proteins are responsible for collagen 
trafficking from the ER to the Golgi (Le Corre et al, 2014). Increases in expression of these proteins 
led to the idea that alterations in ADPKD ECM components could be associated with alterations 
in secretion of ECM proteins from the notochord to the kidney (Le Corre et al, 2014). In fact, 
zebrafish pkd2 morphants treated with Brefeldin A, a pan COPII dependent secretory inhibitor, 
showed a significant reduction in cyst formation as well as a rescue of dorsal axis structure (Le 
Corre et al, 2014). As camk2g1 morphants exhibit the same body curvature as pkd2 morphants, it 
is possible that loss of CaMK-II activity causes an increase in collagen expression which increases 
kidney cells adhesiveness to the ECM during morphogenesis, thereby slowing and/or preventing 
migration (Rothschild et al, 2011). This would also correspond with previous studies, showing that 
pharmacological inhibition of CaMK-II causes a decrease in cell motility and an increase in the 
size of focal adhesion complexes (Easley et al, 2008). 
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Another pathway that may play a role in cellular migration during kidney development is 
the notch signaling pathway. Notch signaling acts through receptor-ligand interactions which 
causes the cleavage of the notch intracellular domain (NICD) (Bray, 2016). The NICD then 
translocates to the nucleus where, through interactions with other regulatory proteins, it mediates 
transcription of its target genes (Bray, 2016). This pathway is involved in a number of biological 
processes including cell fate, stem cell regulation, and heart morphogenesis (Fuss et al, 2004) 
(Bray, 2016). It also has roles in disease pathologies such as certain cancers and polycystic kidney 
disease (Bray, 2016) (Idowu et al, 2018). 
Notch signaling has previously established roles in kidney development through cell fate 
determination of transporting epithelia and multi-ciliated cells in the pronephric ducts (Liu et al, 
2007). In addition, regulation of notch signaling has been previously linked to both CaMK-II and 
HDACs. Pharmacological inhibition of CaMK-II caused a loss of Notch-1 signaling in cell culture 
(Mamaeva et al, 2008) while treatment with TSA, a pan-HDAC inhibitor, reduced Notch-3 protein 
levels in human leukemia cell lines (Pinazza et al, 2018). Inhibited Notch signaling has also been 
linked to reduced cell migration in Drosophila (Fuss et al, 2004). Therefore, it is possible that 
notch signaling components may be the next step in the previously establish pathway of PKD2 
activated CaMK-II regulating HDAC4 during kidney development (Rothschild et al, 2018). It is 
hypothesized that inhibition of CaMK-II will cause a loss of notch signaling, possibly though the 
alterations of the subcellular localization of HDAC4.  
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Methods 
 
Zebrafish Strains and Care 
Zebrafish embryos were obtained though natural matings and raised at 28.5°C (Kimmel et al, 
1995). Zebrafish strains used were Wild-type (AB and WIK), Tg(Tp1:GFP), and 
Tg(NakATPase:GFP) 
 
Morpholino Injections 
Translation-blocking antisense morpholinos were designed to target zebrafish camk2g1 (1ng), 
hdac4 (2ng), and hdac5 (2ng), purchased from Gene Tools along with a control mismatch 
morpholino (2ng). All morpholinos were used as previously described with an injection volume 
of 1nl (Francescatto et al., 2010) (Rothschild et al., 2011) (Rothschild et al., 2013). The 
morpholinos for hdac4 and hdac5 were designed to target the following the regions around the 
translation start site: hdac4: CGCCACACTCACATCAACCATCAGC; nucleotides ‐11 to + 14), 
hdac5: GATCTTCCCTGCCTGAAGTTCTCCA; nucleotides ‐38 to ‐14). 
 
Whole Mount In Situ Hybridization  
Digoxigenin‐labeled antisense riboprobes were synthesized as previously described using T3 or 
T7 RNA polymerase (Rothschild et al., 2007). Embryos used for whole‐mount in situ 
hybridization (WISH) were developed using alkaline phosphatase–conjugated anti‐
digoxigenin. The col9a2 probe was designed using the following primers: Sense 5’ AGGTGCT 
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ACCGGAATGATTG 3’, Antisense 5’ GGATCCATTAACCCTCACTAACGGGAGGTCCAG 
GTCGTCCTG 3’. The col27a1a probe was designed using the following primers: Sense 5’ 
AACCACAAGGGCAAGAATTG 3’, Antisense 5’  CAGGTGTTGTTGTGGTTGGA 3’. DeltaC 
and Col2a1a were provided by Wilson Clements, Ph.D. at St. Jude Children’s Research Hospital. 
Probes for Hdac4 and hdac5 were designed to correspond to sequences amplified using the primer 
sets previously mentioned.   
 
Drug Treatment  
Control zebrafish embryos and camk2g1 morphants were incubated in 5 μM Brefeldin A (BFA) in 
1.9ml of E3 water with 1.0µl PTU starting at 24hpf continuing until fixing at 48hpf.  
 
Fluorescent Localization  
Embryos were fixed in 4% paraformaldeype or Dent’s fixative as previously described (Rothschild 
et al., 2011). Embryos were then incubated with mouse anti‐α 1 Na+/K+‐ATPase (Developmental 
Studies Hybridoma Bank, University of Iowa [α6F] at a 1:10 dilution). After overnight incubation 
in primary antibody, embryos were incubated with the secondary antibody goat anti‐rabbit 
Alexa568 (Invitrogen at 2.5 μg/ml) and imaged using confocal microscopy. Embryos were imaged 
either on a Nikon E600 compound microscope using a 10X dry, 20X dry, or 40X dry objective, or 
on Nikon AZ‐100 Macro Zoom fluorescent stereo microscope. 
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Video Microscopy  
Embryos were imaged by confocal microscopy (Nikon C2 Plus two-laser) on a Nikon Eclipse Ni 
compound microscope using a 20X dry objective or on a Nikon AZ-100 macro zoom fluorescent 
stereo microscope using Elements AR 4.50 software. Embryos used for live imaging for kidney 
migration rates were anesthetized and mounted on a slide using 1.0% low melting agarose (product 
name). Embryos used for tp1 expression images were anesthetized and mounted directly only a 
slide with E3 water. 
 
CaMK-II Expression Constructs 
Kidney targeted WT and K43A CaMK-II expression constructs using the Na+/K+-ATPase promoter 
(Liu et al., 2007) were generated using Gateway technology as previously described (Invitrogen) 
(Francescatto et al., 2010).  
 
DeltaC Rescue 
Hdac4 MO (2ng) and camk2g1 MO (1ng) were co-injected into zebrafish embryos at the one cell 
stage. DeltaC expression was assessed at 24hpf using WISH as described above.  
 
Statistical Analysis  
Statistical significance was set at P<0.05 using the two-tailed t-test  
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Results 
 
Pronephric cell migration is unaffected in DN CaMK-II injected embryos 
In order to assess whether inhibition of CaMK-II affects the rate of migration of kidney 
cells, zebrafish embryos were injected with either a kidney targeted cherry-tagged WT CaMK-II 
or a kidney targeted GFP-tagged dominant negative (DN) CaMK-II which lacks 
phosphotransferase ability. This resulted in embryos with mosaic expression, where florescent 
kidney cells expressed the injected construct and non-fluorescent cells remained unaffected. 
Migration rates were first assessed in WT CaMK-II embryos.  Fluorescent cells present in the 
medial portion of the pronephros moved a total distance of 28.3µm between 50hpf to 55hpf or 
5.6µm/hr (Figure 3.1). This is consistent with previous finding stating that pronephric cells migrate 
faster than their normal 2µm/hr during the time period between 28.5hpf and 3dpf (Vasilyev et al, 
2009). WT CaMK-II positive cells in the distal regions of the kidney migrated slower at 2.2µm/hr 
(data not shown). This is also consistent with previously published data as the distal portion of the 
pronephros is necessary for cell proliferation and not migration (Vasilyev et al, 2009). This rate of 
migration was unaffected by the injection of DN CaMK-II. Kidney cells expressing DN CaMK-II 
had a migrated a total of 22µm from 48hpf to 53hpf, retaining an increased rate of migration of 
4.4µm/hr (Figure 3.2) (Supplemental Video 3.1). Embryos expressing DN CaMK-II also exhibited 
no defects in cell proliferation, as cell division was visible in the distal portion of the pronephros 
(Supplemental Video 3.2).  
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Pronephric cell migration is decreased in camk2g1 morphants  
 In order to evaluate the rate of migration of kidney cells in camk2g1 morphants, 
NakATPase:EGFP embryos were injected with 1ng of camk2g1 morpholino. The rate of migration 
in uninjected embryos was found to be consistent with previous published data (Vasilyev et al, 
2009). Pronephric cells migrated 27.22µm between 49hpf and 50hpf or 5.44µm/hr (Figure 3.3)  
(Supplemental Video 3.3). Camk2g1 morphants do not reach this increased rate of migration. 
Pronephric cells in camk2g1 morphants migrated a total of 8.75µm between 54hpf and 59hpf or 
1.75µm/hr (Figure 3.4) (Supplemental Video 3.4). This migration rate of camk2g1 morphants is 
lower than both uninjected embryos and embryos injected with WT CaMK-II. Interestingly, it’s 
also reduced when compared to embryos injected with DN CaMK-II (Figure 3.5). This could be 
due to the camk2g1 morpholino being more evenly distributed among pronephric cells compared 
to the kidney targeted DN CaMK-II embryos.  
 
Col2a1a expression is increased in camk2g1 morphants  
 Dorsal axis curvature is a common phenotype in zebrafish pkd2 morphants as well as 
camk2g1 morphants (Schottenfeld et al, 2007) (Rothschild et al, 2011). In pkd2 morphants, this 
body curvature was suggested to be due to an increased amount of col2a1a, col9a2, and col27a1a 
expression (Mangos et al, 2010). In order to determine if this is also true for camk2g1 morphants, 
whole mount in situ hybridization was used to assess col2a1a expression at 48hpf in both 
uninjected embryos and camk2g1 morphants. Similar to pkd2 morphants, col2a1a expression was 
dramatically increased in the notochord at 48hpf (Figure 3.6). Col9a2 expression was also found 
to be upregulated in pkd2 morphants. However, it was unchanged in camk2g1 morphants at 48hpf 
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(Figure 3.6). Preliminary data suggest that there may be an increased in col27a1a expression in 
camk2g1 morphants, similar to what was seen in pkd2 morphants (data not shown). However, this 
requires further examination.  
  
Treatment with secretory inhibitor Brefeldin A partially rescue ductal convolution in 
camk2g1 morphants  
 Increases in col2a1a levels in pkd2 morphants was found to be related to an increase in 
complex II Sec proteins pointing to an increase in collagen secretion (Le Corre et al, 2014). 
Treatment with Brefeldin A (BFA) a COPII secretory inhibitor, not only prevented body curvature 
in pkd2 morphants, but also reduced cyst formation as well (Le Corre et al, 2014). As camk2g1 
morphants also exhibit increases in col2a1a expression, it was of interested to determine whether 
treatment with BFA could rescue kidney defects seen in camk2g1 morphants, namely the loss of 
ductal convolution. Treatment with 5µM of BFA did not affect development of uninjected wild 
type embryos but was able to restore ductal convolution in camk2g1 morphants (Figure 3.7) 
(Figure 3.8). Convolution was seen in just under 50% of embryos treated with 5µm of BFA, 
compared to only approximately 20% in untreated camk2g1 morphants (Figure 3.8).  
 
Notch Signaling is decreased in camk2g1 morphants  
 The notch signaling pathway is known to be necessary for kidney morphogenesis (Liu et 
al, 2007). In addition, it has also been linked to both CaMK-II and HDACs in cell culture 
(Mamaeva et al, 2008) (Pinazza et al, 2018). In order to determine if inhibition of CaMK-II is 
altering notch signaling during development, the camk2g1 morpholino was injected into transgenic 
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embryos expressing GFP labeled tp1, a notch response element (Parsons et al, 2009). Tp1 
expression can be seen in the zebrafish cloaca at 24hpf as well as 48hpf (Figure 3.9) However, this 
expression is reduced or lost in camk2g1 morphants (Figure 3.9). Uninjected embryos had an 
average of 3 tp1 positive cells in the cloaca at 24hpf and 5 tp1 positive cells at 48hpf. This number 
was significantly decreased in camk2g1, where most embryos have no tp1 expression at 24hpf and 
only 2-3 positive cells at 48hpf (Figure 3.10, p<.05).  
 
DeltaC expression is increased in the cloaca in camk2g1 morphants and hdac5 morphants 
 In order to further investigate the connections between notch signaling and the CaMK-II-
HDAC4 pathways during kidney morphogenesis, expression of the notch ligand deltaC was 
assessed using WISH in embryos injected with the camk2g1 MO, hdac4 MO, or the hdac5 MO. 
DeltaC expression was unchanged in HDAC4 morphants, but was increased in the cloaca in hdac5 
morphants (Figure 3.11). Inhibition of camk2g1 also caused an increase in deltaC expression in 
the cloaca at 24hpf (Figure 3.11). This increase in expression was not seen at 48hpf (Figure 3.12). 
The increase in deltaC expression is consistent with previous findings on the regulation of Delta 
ligands by CaMK-II in the inner ear, where camk2g1 morphants shows increased levels of deltaA 
and deltaD expression (Rothschild et al, 2013). The increase in deltaC expression seen in camk2g1 
morphants could indicate a feedback loop in which a loss of response from the receptor could 
signal for increased ligand production in an effort to complete the signaling pathway.  
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Suppression of HDAC4 in camk2g1 morphants rescues deltaC expression 
 Pronephric duct convolution is lost when camk2g1 activity is inhibited and is able to be 
rescued with co-suppression of hdac4. In order to determine whether hdac4 is able to have the 
same effect on the notch signaling pathway, deltaC expression was assessed in embryos injected 
with both the hdac4 MO and camkg1 MO. DeltaC expression is increased in the cloaca at 24hpf 
in camk2g1 morphants. (Figure 3.11).  This increased expression is prevented in camk2g1 
morphants with suppressed hdac4 (Figure 3.13). This suggest a possible role for CaMK-II-HDAC4 
pathway in the regulation of notch signaling during kidney morphogenesis, This could occur 
through direct regulation of deltaC expression or through regulation of the Notch receptors, as 
CaMK-II has previously been shown to regulate Notch signaling in cell culture (Ann et al., 2012) 
(Mamaeva et al., 2009).  
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Discussion 
 
 This study aimed to investigate the role of CaMK-II in the previously reported migratory 
defects associated with zebrafish models of ADPKD. Inhibition of camk2g1 in zebrafish embryos 
causes a loss of cell migration in kidney cells (Rothschild et al, 2011). This study has determined 
that this could be due to an inability of migrating cells to reach an increased rate of migration 
normally seen between 28.5hpf and 3dpf (Vasilyev et al, 2009).  
 Formation of the zebrafish pronephros is reliant upon the anterior migration of pronephric 
cells to a specific location where they can convolute inward and connect with the glomerulus 
(Vasilyev et al, 2009). This migration occurs collectively, with cells maintaining apical cell-cell 
junctions. Cell migration is initiated at the start of active fluid transport to the pronephros, after 
which migrating cells form transient focal adhesion complexes with the basement membrane, 
while extending lamellipodia in the direction of movement (Vasilyev et al, 2009).  
The formation and subsequent disassembly of focal adhesion complexes is an integral step 
in cell migration as cells use them as anchor points to pull themselves along during migration. 
Focal adhesion complexes are multi-protein structures that form when integrins in the migrating 
cell interact with the ECM, inducing autophosphorylation of focal adhesion kinase (FAK), which 
in turn recruits src, paxillin, and a number of other focal adhesion proteins (Easley et al, 2008). 
Disassembly of focal adhesion complexes is associated with transient elevations in Ca2+ and 
CaMK-II has been shown to have a role in focal adhesion turnover by inducing the 
dephosphorylation of FAK and paxillin (Easley et al, 2008). 
 In cell culture, alterations in CaMK-II activity inhibited cell motility and caused alterations 
in FAK and paxillin phosphorylation in focal adhesion complexes (Easley et al, 2008). 
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Pharmacological inhibiton of CaMK-II over stabilized paxillin and caused an increase in the size 
of focal adhesion complexes (Easley et al, 2008). Conversely, constitutively active CaMK-II 
caused a decrease in FAK and paxillin phosphorylation, resulting in a decrease in cell motility as 
cells were less adhesive to the ECM (Easley et al, 2008).  
In this study, camk2g1 morphants exhibited a slower rate of migration during the time 
period in which increased migration rate in essential in order to form a functional kidney. As 
previous research has indicated that loss of CaMK-II causes over stabilization of focal adhesion 
complex, it is possible that there is a loss of focal adhesion turnover in camk2g1 morphants, 
inhibiting migration. Future research should focus on assessing expression of focal adhesion 
proteins during kidney morphogenesis, specifically FAK and paxillin as these are known to be 
responsive to alteration in CaMK-II activity.  
It is of note that this decrease in migration was only seen in embryos injected with the 
camk2g1 morpholino and not in embryos injected with the DN form of CaMK-II, K43A. This could 
be due to the more even distribution of the morpholino among kidney cells. In the course of this 
study, injection of the DN CaMK-II construct produced fluorescence in approximately 10 or less 
kidney cells per embryos and often these were distributed along the length of the pronephros, 
occurring primarily in the medial and distal portions. Previously, expression of DN CaMK-II was 
shown to cause significant decreases in cell migration as well as cause abnormal branching in the 
pronephros. However, in that instance, positive cell were clustered at the anterior end as opposed  
to being more evenly distributed as seen in this study (Rothschild et al, 2011). As kidney cells 
migrate collectively, with each cell maintaining cell junctions while following the path of the cell 
on the leading end, it is likely that the disruption in migration was caused by the leading edge cells 
expressing DN CaMK-II (Rothschild et al, 2011). In the current study, the leading edge cells 
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remained wild type, while the cells expressing DN CaMK-II were medial and distal. Therefore, it 
is likely that because the cells migrate collectively, the wild type cells were able to compensate for 
any defects in the GFP positive cells in the middle, preventing any alterations in migration rate.  
In addition to alterations in focal adhesion complexes, this study points to another potential 
pathway where an increase in col2a1a in camk2g1 morphants may be a cause of reduced migration. 
Collective cell migration is reliant upon formation and disassembly of focal adhesion between 
migrating cells and the extracellular matrix (ECM) (Vasilyev et al, 2009). As increases in collagen 
density have been reported to slow or prevent migration in cell culture, increase in collagen 
expression may be preventing migration during kidney development (Kuzcek et al, 2019). This is 
further supported by a reduction in kidney defects with treatment of Brefeldin A, a secretory 
inhibitor previously shown to reduce secretion of col2a1a in pkd2 morphants (Vasilyev et al, 
2009). This potential pathway requires further examination, with future studies focusing on 
expression of kidney specific collagen protein, such as col27a1a, and other secretory proteins in 
camk2g1 morphants.  
This study has also identified CaMK-II regulation of notch signaling as a potential pathway 
of interest. This is supported by a decrease in tp1 expression in the cloaca at 24hpf and 48hpf. 
Inhibition of camk2g1 also caused an increase in deltaC expression in the cloaca, suggesting a 
feedback loop where increased expression of the notch ligand is attempting to compensate for the 
loss of response from the receptor (Ma and Jiang, 2007). The increase in deltaC was able to be 
rescued by suppression of hdac4, mimicking previous research where inhibition of hdac4 was able 
to partially rescue kidney defects in camk2g1 morphants.  
It is possible that camk2g1 regulation of notch signaling may play a role in cellular 
migration. Alterations in notch signaling components were seen in the cloaca, which is the sight 
57 
 
at which inhibition of camk2g1 was shown to cause a loss of cloacal cilia, potentially inhibiting 
the fluid flow necessary for migration (Rothschild et al, 2011). In addition, murine cell culture 
transfected with a constitutively active form of the notch 1 receptor had decreased expression of 
type II collagen, suggesting that the notch signaling pathway may play a role in collagen regulation 
(Blaise et al, 2009). Therefore a potential pathway may be that notch activity, regulated by the 
previously established CaMK-II-HDAC4 pathway, is providing a similar function during kidney 
morphogenesis, and its inhibition is resulting in increased collagen expression and reduced 
migration.  However, this pathway is speculative, and requires further study for validation.  
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Figure 3.1. Migration distance in WT CaMK-II embryo. Embryos were injected with 100ng of 
the WT CaMK-II construct Cherry:CaMK-II. Embryos were imaged every 15 minutes between 
50hpf and 55hpf. The imaged cell moved a total of 28.31µm over the five hour time period or 
5.66µm/hour 
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Figure 3.2. Migration distance in DN CaMK-II embryo. Embryos were injected with 100ng of 
the DN CaMK-II construct GFP-K43A. Embryos were imaged every 15 minutes between 48hpf 
and 53hpf. The imaged cell moved a total of 22µm over the five hour time period or 4.4µm/hour.  
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Figure 3.3. Migration distance in NakATPase:EGFP embryos. NakATPase:EGFP embryos 
were imaged every 15 minutes between 49hpf and 59hpf. Imaged cells moved an average of 
27.22µm over the five hour time period or 5.44 µm/hour. 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
 
Figure 3.4. Migration distance in camk2g1 morphants. NakATPase:EGFP embryos were 
injected with 1ng of camk2g1 morpholino. Embryos were imaged every 15 minutes between 54hpf 
and 59hpf. The imaged cell moved a total of 8.75µm over the five hour time period or 
1.75µm/hour.  
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Figure 3.5.  Average migration distance WT and CaMK-II inhibited embryos. Migration 
rates were analyzed in embryos injected with 100ng of Cherry:CaMK-II, 100ng of DN CaMK-II 
construct,  or 1ng of camk2g1 MO, as well as uninjected NakATPase:EGFP embryos. There was 
no difference in migration rates between WT CaMK-II (number of positive cells = 3), DN 
CaMK-II (number of positive cells = 6), or NakATPase:EGFP embryos (number of positive cells 
= 3). However, preliminary data suggest there may be a decrease in cell migration rates in 
camk2g1 morphants (number of positive cells = 2).   
 
 
 
63 
 
 
 
Figure 3.6. Col2a1a expression is increased at 48hpf in camk2g1 morphants. Col2a1a and 
Col9a2 expression was assessed at 48hpf using anti-sense RNA probes and WISH. Col2a1a 
expression is increased in the notochord at 48hpf in camk2g1 morphants (n=9) when compared 
to control (n=8). Col9a2 is unchanged in camk2g1 morphants (n=7) when compared to control 
(n=6).  
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Figure 3.7: Ductal convolution in camk2g1 morphants treated with secretory inhibitor 
Brefeldin A (BFA). Anterior convolution was assessed at 48hpf in camk2g1 morphants treated 
with secretory inhibitory, Brefeldin A. Convolution was observed by immunostaining the kidney 
specific NaKATPase in untreated controls (A, D), untreated camk2g1 morphants (B, E), and 
camk2g1 morphants treated with 5µM of Brefeldin A (C, F).  
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Figure 3.8. Ductal convolution in camk2g1 morphants treated with secretory inhibitor 
Brefeldin A (BFA). Anterior convolution was assessed at 48hpf in controls (n=19), controls 
treated with 5µM BFA (n=11), camk2g1 morphants (n=19), and camk2g1 morphants treated with 
5µM of BFA (n=20).  
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Figure 3.9. Tp1 expression in control embryos and camk2g1 morphants. The number of GFP 
positive cells in the cloaca was assessed in uninjected Tp1:GFP embryos and in Tp1:GFP 
embryos injected with 1ng of camk2g1 morpholino at 48hpf. Camk2g1 morphants have a loss of 
tp1 expression at 48hpf.  
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Figure 3.10. Number of tp1 positive cells in the cloaca in camk2g1 morphants. The number of 
GFP positive cells in the cloaca was assessed in uninjected Tp1:GFP embryos and in Tp1:GFP 
embryos injected with 1ng of camk2g1 morpholino. Embryos were assessed at 24hpf (A, control 
n=25, camk2g1 MO n=25) and again at 48hpf (B, control n=12, camk2g1 MO n=15).  
 
 
 
 
 
 
 
 
 
 
68 
 
 
Figure 3.11. Inhibition of camk2g1 and hdac5 causing an increase in deltaC expression in the 
cloaca at 24hpf. Embryos were injected with 1ng of camk2g1 MO, 2ng of hdac4 MO, or 2ng 
hdac5 MO. DeltaC expression was assessed using an anti-sense RNA probe and WISH at 24hpf.  
 
 
69 
 
 
Figure 3.12. DeltaC expression is unchanged at 48hpf. Embryos were injected with 1ng of 
camk2g1 MO at the 1-4 cell stage. DeltaC expression was visualized at 48hpf using an anit-sense 
RNA probe and WISH. DeltaC expression was unchanged in camk2g1 morphants (n=16) at 48hpf 
when compared to controls (n=20) 
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Figure 3.13. DeltaC expression is restored to wildtype level in camk2g1 MO with co-inhibition 
of hdac4. Embryos were co-injected with 1ng of camk2g1 MO and 2ng hdac4 MO. DeltaC 
expression was assessed at 24hpf using WISH.  
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Supplemental Video 3.1. Migration Rate of Kidney Cells in a DN CaMK-II Embryo. Live 
imaging of a DN CaMK-II injected embryo taken between 48hpf and 53hpf showing pronephric 
cells migrating at a rate of 4.40µm/hr 
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Supplemental Video 3.2. Cell Division in a DN CaMK-II Embryo. Live imaging of a DN 
CaMK-II injected embryo showing cell division in the distal portion of the pronephros. 
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Supplemental Video 3.3. Migration Rate of Kidney Cells in a NaKATPase:EGFP Embryo. 
Live imaging of a NaKATPase:EGFP embryo taken between 50hpf and 55hpf showing pronephric 
cells migrating at a rate of 5.44µm/hr. 
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Supplemental Video 3.4. Migration Rate of Kidney Cells in camk2g1 Morphant Embryo. 
Live imaging of a camk2g1 morphant embryo taken between 54hpf and 59hpf showing pronephric 
cells migrating at a rate of 1.75µm/hr. 
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Chapter 4: Genetic compensation in camk2g1 mutants 
 
Abstract 
  
CaMK-II is a Ca2+/calmodulin depending protein kinase encoded by 4 genes (α, β, γ, δ) in 
humans, and 7 genes (α, β1, β2, γ1, γ2, δ1, δ2) in zebrafish. Since being first described in the 
1970s, CaMK-II has been found in virtually every tissue type and is involved in a variety of cellular 
processes including long term potentiation, ion channel regulation, and organogenesis. In zebrafish 
embryos with inhibited camk2g1, a variety of developmental defects can be seen including defects 
in kidney morphogenesis, the development of pronephric kidney cysts, left-right asymmetry 
defects, hydrocephaly, ciliary instability, and aural defects. In an effort to further understand the 
roles of camk2g1 during development, a homozygous mutant was generated in zebrafish using 
TALEN technology. However, the mutant exhibited none of the phenotypic defects seen in 
zebrafish camk2g1 morphants. qPCR analysis of CaMK-II expression in camk2g1 mutant embryos 
showed a 3.5 fold increase in camk2g2, its paralog. In addition, several of the other CaMK-II genes 
showed a decrease in expression up to 40%, suggesting genetic cross-talk during development. 
Generation of G0 camk2g1 mutants using CRISPR/Cas9 exhibited nearly all of the defects seen in 
camk2g1 morphants, including kidney defects, cyst development, and ciliary defects. These results 
validate the camk2g1 morphant phenotype seen in current and previous studies, and indicate that 
genetic compensation does not occur in morphants or G0 mutants, but is developed over time in 
stable mutant lines.  This study demonstrates the ability of CaMK-II genes to genetically 
compensate for the loss of their paralog and validates the use of knockdown methods such as 
morpholinos for future developmental studies.  
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Introduction  
 
TALEN and CRISPR/Cas9 Genome Editing 
 Transcription activator-like effectors (TALEs) are proteins secreted by bacteria that 
contain a DNA binding domain enabling them to effect gene transcription in vivo (Nemudryi et 
al, 2014). The DNA binding domain of TALEs proteins is formed by monomers made from 34 
amino acids with a variable region at positions 12 and 13 (Moscue and Bogdanove, 2009). These 
positions follow a specific code enabling targeting to one of the four nucleotides based upon which 
two amino acids are present in the variable region. The amino acid in position 12 is necessary for 
stabilization and the amino acid in position 13 directly interacts with the targeted nucleotide 
(Moscue and Bogdanove, 2009)  
. Once this system was understood, an artificial DNA binding domain was created and 
placed in a construct with the catalytic domain of FokI, a restriction endonuclease, yielding the 
transcription activator-like effector nucleases (TALEN) genome editing method (Nemundryi et al, 
2014). This method allows for the use of TALEs monomers designed to target specific regions of 
DNA. TALENs are used in pares and are designed to sit on opposite strands of the targeted 
sequence (Nemudryi et al, 2014). The FokI domains on the C-terminus end of the TALENs 
dimerize with their counterpart on the opposite strand, causing a double stranding break. This 
break is then repaired by nonhomologus end joining (NHEJ) an error prone process that often 
causes insertions or deletions disrupting the function of the target gene (Lieber, 2010) (Nemudryi 
et al, 2014).  
 Another reliable, commonly used method of genome editing is the CRISPR/Cas9 system. 
This method is also derived from bacteria (Nemudryi et al, 2014). However, in contrast to the 
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TALEN system, CRISPR/Cas9 relies upon a complex consisting of non-coding RNA and the Cas9 
endonuclease. In bacterial cells, a small sequence of invading DNA is inserted into the CRISPR 
locus (Nemundryi et al, 2014). This sequences is complementary to the sequence on the foreign 
DNA which is located near a specific region known as the PAM (protospacer adjacent motif) 
sequence necessary for the targeting of the CRISPR/Cas9 complex (Mojica et al, 2009). After 
insertion of the fragment of foreign DNA into the CRISPR locus, it is transcribed, allowing for 
targeting of the CRISPR/Cas9 complex to the invading DNA, enabling its degradation (Nemudryi 
et al, 2014).  
 The use of CRISPR/Cas9 in research settings has become a common and reliable method 
of genome editing. In mice and zebrafish, the typical method used is to create a single guide RNA 
which consist of a designed crRNA targeting the area of interest in the genome and the tracrRNA 
which enables the activity of the CRISPR/Cas9 complex. This is microinjected along with either 
Cas9 protein or mRNA (Chang et al, 2013) (Wang et al, 2013). Similar to the TALEN system, 
once the CRISPR/Cas9 complex binds to its target site, a double stranded break occurs. This break 
in then repaired by the error prone NHEJ, leading to inhibition of activity of the target gene 
(Nemudryi et al, 2014).  
Although the CRISPR/Cas9 system has proven to be a reliable method for gene editing, 
some genes have proven resistant to targeted mutations (Gagnon et al, 2014). In order for the 
CRISPR/Cas9 system to be effective, a double stranded break must generate a repair that causes a 
frameshift mutation and/or a premature stop codon (Nemudryi et al, 2014). In 2014, researchers 
attempted to use CRISPR/Cas9 to generate a zebrafish camk2g1 mutant. Microinjection of sgRNA 
and Cas9 mRNA was able to successfully generate alteration in the camk2g1 gene in 8 injected 
zebrafish embryos. However, none of these insertion/deletions generated a frameshift, leaving a 
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fully function protein, suggesting biological repair mechanisms designed to reduce allele diversity 
(Gagnon et al, 2014). 
 
Genetic Compensation 
The use of genome editing methods like TALEN and CRISPR/Cas9 have become the 
standard in reverse genomic studies. However, research has shown discrepancies between the 
phenotypes of stable mutants and morphants for particular genes. In fact, a  study comparing the 
phenotypes of mutants and morphants for 24 specific genes found that only 5 of the compared 
genes shared a similar phenotype (Kok et al, 2015). This was further demonstrated through their 
own study where 10 of the developed and validated zebrafish mutant lines showed none of the 
developmental defects previously published in morphants for the same genes. This led researchers 
to the conclusion that many morphant phenotypes are due to off target effects of the morpholino 
and are not reliable descriptions of gene function (Kok et al, 2015).  
The discrepancy between mutant and morphants phenotypes have been described in a 
variety of model organism including zebrafish, mice, and human cell lines (Kok et al, 2015) 
(Daude et al, 2012) (Karakas et al, 2007). Although this was originally thought to be due to off 
target effects of knockdown mechanisms, recent studies have indicated that genetic compensation 
in mutant models may be preventing any developmental defects to due genetic loss (El-Brolosy 
and Stainier, 2017). A comparison between a zebrafish mutant and morphant for egf17, an 
extracellular matrix gene, showed opposing phenotypes, with egf17 mutants developing normally 
and egf17 morphants having severe vascular defects. Addition analysis found that other 
extracellular matrix genes were upregulated in egf17 mutants, not in morphants indicating 
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compensation by these genes (Rossi et al, 2015). Other studies have produced similar results, 
where zebrafish mutants for epoa, a red blood cell regulator, have increased levels of epob 
expression, preventing developmental defects (She et al, 2019).   
Genetic compensation has been well reported in a variety of studies using a number of 
model organisms. However, the exact mechanisms of genetic compensation are currently 
unknown. Based upon previously reported studies, several possible explanations exists for the 
induction of genetic compensation in mutant models. One thought is that DNA damage causes 
epigenetic changes that induce genetic compensation (El-Brolosy and Stainier, 2017).  When DNA 
is damaged in some way, chromatin remodelers and histone-modifying enzymes act to de-
condense and reorganize chromatin (El-Brolosy and Stainier, 2017). It has been proposed that 
when a mutation occurs, these same mechanism may de-condense chromatin around compensating 
genes inducing their upregulation. This idea has been supported by studies in both Drosophila and 
C elegans (Stukenholz et al, 1999) (Raj et al, 2010).    
Another proposed method for genetic compensation is that compensation is induced by the 
presence of mutant mRNA (El-Brolosy and Stainier, 2017). The presence of mutant mRNA 
induces the nonsense mediated decay (NMD) pathway (Schuermann, et al, 2015). In zebrafish, 
two different mutations were made in the same exon for the gene mt2 which caused two different 
levels of NMD activation. The mutant with the higher level on NMD had lesser phenotypic defects 
that the mutant with lower levels of NMD response (Schuermann et al, 2015). Several potential 
pathways have been proposed for how the presence of mutant mRNA can induce genetic 
compensation. One potential pathway is that mutant mRNA acts to bring transcription factors and 
chromatin remodelers to the site of compensation genes (El-Broslosy and Stainier, 2017). It has 
also been proposed that mutant mRNA could also act through RNA binding proteins (RBPs). RBPs 
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act to stabilize mRNA and if the mutant mRNA is unable to bind to the RBPs then they would 
become available to stabilize the compensating genes (El Broslosy and Stainier, 2017).  
In this study, a zebrafish mutant for the gene camk2g1 was analyzed for the presence of 
genetic compensation. Previous research has shown that inhibition of camk2g1 using morpholinos 
and dominant negative constructs yielded embryos with severe phenotypic defects including 
hydrocephaly, left-right asymmetry defects, kidney defects, and body curvature (Francescatto et 
al, 2010) (Rothschild et al, 2011) (Rothschild et al, 2018). The camk2g1 mutant possesses none of 
these defects and develops normally. This study aims to validate previously published works on 
camk2g1 using knockdown mechanisms while also investigating genetic compensation by other 
CaMK-II family members in camk2g1 mutants.  
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Methods 
 
Zebrafish strains and care 
Wild type (AB and WIK) fish embryos were obtained through natural matings and raised at 28.5°C 
as previously described (Kimmel et al., 1995). 
 
Generation of camk2g1 mutant zebrafish and sequence analysis  
Camk2g1 mutants were generated and provided by the Thisse lab using the following protocol. 
The TALEN to target camk2g1 was designed using TAL Effector Nucleotide Targeter 2.0 
(https://tale-nt.cac.cornell.edu/node/add/talen-old), assembled by using the Golden Gate TALEN 
and TAL Effector Kit 2.0 (Cermak et al., 2011) and cloned into the pCS2+TAL3DD or 
pCS2+TAL3RR (Dahlem et al., 2012). The sequence in the exon 2: TTGCAGGGGTGCCTTCT 
CcgtggtgcggagatgtgTGAAAAAATCCACTGGCCA has been targeted using the TALEN 
modules= NG NN HD NI NN NN NN NN NG NN HD HD NG NG HD NG HD and NN NN HD 
HD NI NN NG NN NN NI NG NG NG NG NG NG HD NI. Synthesized capped mRNAs were 
injected into eggs of the AB/Tu strain. Characterization of mutant alleles in F1 adults was assessed 
by performing an endonuclease assay using AciI that cuts at GCGG (underlined in the sequence 
above) in the linker sequence. The primers used to amplify the DNA fragment around the target 
site were 5’- TGCATGCGCTATAAGGTGCATTGT-3’ and 5’-GCAACCACACAG 
ACACCCTCG-3’. PCR amplification of genomic DNA with these primers (Meeker et al., 2007) 
results in production of a 329 bp fragment that is cut into fragments of 88 bp and 241 bp by the 
AciI endonuclease. AciI resistant fragments potentially carrying mutations were cloned into 
pCR2.1 TOPO and sequenced. F1 frame shift mutations predicted to truncate the translated 
camk2g1 protein were crossed with each other to generate F2 homozygous mutant embryos. 
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Crosses between camk2g1 heterozygous adults identified at each generation with the genotyping 
method described above were used to maintain the mutant strain population. Mutations were 
confirmed by PCR amplification of camk2g1 exon2 followed by sequencing. 
 
Measurement of CaMKII activity 
Control, camk2g1 mutants, and embryos injected with the camk2g1 translation blocking 
morpholino (MO) were dechorionated and lysed as previously described. Total CaMKII activity 
was assessed by measuring phosphate incorporation into autocamtide2, as previously described 
(Rothschild et al., 2007). 
 
Morpholino injections 
 Translation-blocking antisense morpholino oligonucleotide (MO) were used to target zebrafish 
camk2g1 and camk2g2. The camk2g1 MO (1ng or 0.5ng) and the camk2g2 MO (10ng) were 
previously described and validated (Francescatto et al., 2010; Rothschild et al., 2011; Rothschild 
et al., 2013).  
 
Immunofluorescence and Microscopy 
Fluorescent and transmitted light micrographs were acquired using a Nikon AZ100 macro zoom 
fluorescent stereo microscope. For fluorescent localization, embryos were fixed in 4% 
formaldehyde/PBS or Dent’s fixative as previously described (Rothschild et al., 2011). Fixed 
embryos were incubated with mouse anti-acetylated -tubulin (Sigma Chemical Co. (T7451) at 2 
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g/ml) or mouse anti-1 Na+/K+-ATPase (Developmental Studies Hybridoma Bank, University 
of Iowa (6F) at a 1:10 dilution). Primary antibody incubations were overnight and were followed 
by either goat anti-mouse Alexa488 or goat anti-rabbit Alexa568 (Invitrogen at 2.5 g/ml). 
Embryos were imaged by confocal microscopy (Nikon C2 Plus two-laser) on a Nikon Eclipse Ni 
compound microscope using a 20X dry objective or on a Nikon AZ-100 macro zoom fluorescent 
stereo microscope using Elements AR 4.50 software. 
 
Quantitative PCR 
Embryos were collected from control and camk2g1 mutant embryos at 24 hours post fertilization 
(hpf), dechorionated, and total RNA was extracted as previously described (Rothschild et al., 2009; 
Rothschild et al., 2007). Concentration and purity of total RNA was assessed using a Nanodrop 
1000 spectrophotometer (Thermo Fisher Scientific). cDNA was prepared as previously described 
using approximately 1µg of RNA per reaction (Rothschild et al., 2009; Rothschild et al., 2007). 
qPCR primers were designed against all seven transcriptionally active CaMKII genes (Table 4.1). 
All reactions were performed in triplicate using 2x SensiFAST SYBR No-ROX Mix (Bioline, 
BIO-98005). qPCR analysis was performed using a micPCR system (Bio Molecular Systems, 
M0000636). Single product amplification was confirmed using both a melt curve and direct 
sequencing of the product. Gene expression fold change was analyzed using the 2 -ΔΔCT method and 
was normalized to elongation-factor 1-alpha (ef1α) (Silver et al., 2006). 
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RT-PCR and Sequencing  
Total RNA from control and camk2g1 mutant embryos at 24hpf was prepared as described above. 
PCR primers were designed to amplify the variable domain and were used as previously described 
(Rothschild et al., 2007). PCR products were cloned into the pSC-A vector (Agilent) and 
sequenced to identify CaMKII gene specific splice variants. 
 
Camk2g1 CRISPR/Cas9 G0 embryos  
Four guide RNAs (gRNAs) against camk2g1 were designed using the Dharmacon CRISPR design 
tool. Two were designed to target the 5’UTR (CCCGTGACTCTGCTGATTGC, 
ATACTACCCATGTAGCTTTG), one was designed to target exon 1 (TGTAACCTCG 
ACCAGGTTTA), and one was designed to target exon 2 (GGGGTGCCTTCTCCGTGGTG). The 
two gRNAs targeting the 5’UTR region were ordered from the Synthego Corporation using their 
CRISPRevolution sgRNA EZ Kit. The gRNAs targeting exon 1 and exon 2 were designed with 
the addition of a T7 promoter region (TAATACGACTCACTATA) as well as a constant overlap 
region (GTTTTAGAGCTAGAAATAGC). Promega GoTaq Hot Start Green Master Mix (M5122) 
with gRNA primers (GCGTAATACG ACTCACTATAG, AAAGCACCGACTCGGT GCCAC), 
and constant region oligonucleotides (AAAAGCACCGACTCGGTGCCACTTTTTC 
AAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTA GCTCTAAAAC) were 
used to generate the gRNA templates using the following thermocycler conditions: 40 cycles of 
95°C for 15 seconds, 60°C for 30 seconds, and 72°C for 20 seconds. The final template was 
purified using the GENECLEAN II Kit (MP Biomedicals 1001400). The transcription reaction 
was performed using the MEGAshortscript T7 High Yield Transcription Kit (AM1354) with a 
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final purification using the RNA Clean & Concentrator Kit (Zymo Research R1015). The four 
gRNAs were coinjected at 200ng/l each with Cas9 protein (1ng) (New England Biosciences) into 
onecell stage zebrafish embryos. Insertion/deletions were verified by PCR amplification and 
sequencing. Primers for camk2g1 5’ UTR (1) (CACTCACTCACACACACAAACAC, CATTTT 
AACAATGGGCGAGAG), camk2g1 5’ UTR (2) (GCCACTCTCGCCCATTGTTAAAATG, 
CGGGAGGAGAATCTCATGTGGTCC), camk2g1 exon1 (CTCCGTTCTTTCTCTCTCTGG 
AC, TACAATGTTGCGCGCACTTAC). 
 
Video Microscopy 
Live embryo cilia videos were acquired at 72hpf under differential interference contrast optics 
using a Nikon 60X water immersion Plan APO objective and 20 frames per second acquisitions 
after transient anesthesia and immobilization in low melting point agarose, as previously described 
(Rothschild et al., 2011).  
 
Statistical methods  
Statistical analysis used the two-tailed t-test and significance was set at P<0.05. 
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Results  
 
Camk2g1 mutants show no gross morphological defects 
 Camk2g1 mutant embryos were generated by the Thisse lab using TALEN technology 
which induced a pre-mature stop codon in exon 2. This stop codon occurred in the catalytic domain 
by the addition of 8 nucleotides and the loss of 6, producing an inactive kinase (Figure 4.1 A). The 
mutants are homozygous viable through 8 generations. Analysis of gross morphology show no 
morphological defects in the camk2g1 mutants when compared to controls (Figure 4.1 B-G). This 
is in sharp contrast to previous studies inhibiting camk2g1 activity through the use of morpholinos, 
dominant negative, and pharmacological inhibition (Francescatto et al, 2010) (Rothschild et al, 
2011) (Rothschild et al, 2013) (Rothschild et al, 2018). Studies using the previously stated methods 
resulted in embryos that exhibited defects that include body curvature, hydrocephaly, left-right 
asymmetry defects, and kidney abnormalities. Analysis of CaMK-II activity showed 20-30% 
decrease in total CaMK-II activity in camk2g1 mutants when compared to controls, demonstrating 
successful loss of function in mutant embryos (Figure 4.1 H) 
 
Camk2g1 mutants show no morphological defects when injected with camk2g1 morpholino 
 The loss of camk2g1 in homozygous mutants causes no morphological defects, in contrast 
to previous studies using morpholinos to suppress activity (Francescatto et al, 2010) (Rothschild 
et al, 2011) (Rothschild et al, 2013) (Rothschild et al, 2018). In an effort to further validate the 
specificity of the camk2g1 morpholino, camk2g1 mutant embryos were injected with 1ng of the 
camk2g1 morpholino and morphology was compared to controls, un-injected mutant embryos, and 
camk2g1 morphants. As previously reported, camk2g1 mutants produce no morphological defects 
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when compared to control embryos (Figure 4.2 A-C, G-I) Camk2g1 morphants exhibit dorsal-axis 
curvature, hydrocephaly, and defects in cloacal morphology (Figure 4.2 D-F). The injection of 1ng 
of camk2g1 morpholino into camk2g1 mutant embryos showed none of the defects seen in 
morphants embryos, with no body curvature present, normal cloaca formation, and no visible brain 
defects (Figure 4.2, J-L). Analysis of percent inhibition of CaMK-II activity in camk2g1 mutants 
confirm a loss of CaMK-II activity by almost 30%. However, embryos injected with .5ng or 1ng 
of camk2g1 morpholino show a greater loss than the camk2g1 mutants. Embryos injected with 
.5ng have a 40% loss of CaMK-II activity while embryos injected with 1ng of camk2g1 
morpholino have a 60% loss (Figure 4.2 M).  
 
Camk2g1 mutants show no kidney defects when injected with camk2g1 morpholino 
 Inhibition of camk2g1 caused severe defects in kidney development in zebrafish embryos 
that include loss of cell migration, loss ductal convolution, cloacal cilia loss, and the development 
of pronephric cysts (Rothschild et al, 2011) (Rothschild et al, 2018). Kidney development was 
evaluated in camk2g1 morphants, camk2g1 mutants, and camk2g1 mutants injected with 1ng of 
camk2g1 morpholino. Consistent with previous finding, camk2g1 morphants pronephros failed to 
convolute and had a significant increase in ear-kidney distance indicating a loss of cellular 
migration (Figure 4.3 A-B, E-F, p<.05). Camk2g1 mutant embryos had normal pronephric 
development when compared to controls, with over 90% of the embryos having convolution of the 
pronephric ducts and an ear-kidney distance equivalent to controls (Figure 4.3 C, E-F, p<.05). 
Camk2g1 mutants injected with the camk2g1 morpholino also had normal kidney development, 
with convolution in over 90% of embryos and normal kidney cell migration (Figure 4.3 D, E-F, 
p<.05) (n=20-35 per condition) 
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 Cloacal cilia formation and stability was also assessed in camk2g1 morphants, camk2g1 
mutants, and camk2g1 mutants injected with 1ng of camk2g1 morpholino. Previous studies have 
shown that embryos with suppressed camk2g1 lose cloacal cilia formation and stability and have 
cloacal occlusions (Rothschild et al, 2011) (Rothschild et al 2018). Camk2g1 morphants mimicked 
previous studies, with a reduction in the number of cloacal cilia from an average of 12 to 2 as well 
as significant decrease in the length of remaining cilia (Figure 4.3 G-H, p<.05). Camk2g1 mutants 
exhibited no changes in cloacal cilia number or length when compared to controls. This was also 
true for camk2g1 mutants injected with the camk2g1 morpholino (Figure 4.3 G-H, p<.05). These 
results are consistent with a total loss of camk2g1 in mutant embryos as well as demonstrates the 
specificity of the morpholino. (n=20 embryos per condition and n=20-50 cilia per condition) 
 
Genetic Compensation in Camk2g1 Mutants 
 In an effort to understand the discrepancy between the phenotypes of camk2g1 mutants and 
morphants, expression of all 7 CaMK-II genes were assessed using qPCR to look for evidence of 
genetic compensation. Validated primer sets were used to assess expression of the 7 CaMK-II 
genes in zebrafish at 24hpf in camk2g1 mutants and control embryos. Results showed a 40-90% 
decrease in transcript level in camk2a, camk2b1, camk2b2, camk2d1 and camk2d2 while transcript 
levels of camk2g2 were increase over 3 fold in camk2g1 mutants (Figure 4.4 A). This increase in 
expression of camk2g2 persists at 48hpf as did the decrease in camk2a, camk2b2 and camk2d1 
expression (Figure 4.5) This increase in camk2g2 expression was further validated by amplifying 
and cloning the variable domains of CaMK-II genes in control and camk2g1 mutant embryos. 
Sequencing of obtained clones showed an increase in the presence of clones expressing camk2g2 
compared to controls. In addition, clones obtained were both nuclear and cytosolic targeted in both 
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control and mutant embryos, with two new camk2g2 splice variants being identified in clones 
obtained from camk2g1 mutants. This not only supports the hypothesis of genetic compensation 
by camk2g2 in camk2g1 mutants but also provides a potential role of camk2g1 regulation of other 
isoforms (Figure 4.4 B-D).  
 In order to validate the role of camk2g2 compensation in camk2g1 mutants, a morpholino 
was used to suppress activity of camk2g2 in wild type embryos and camk2g1 mutants. Embryos 
injected with 10ng of the camk2g2 morpholino show no gross morphological defects and had no 
defects in left-right asymmetry when compared to controls. However, when camk2g1 mutants 
were injected with the camk2g2 morpholino, there was a loss of left-right asymmetry in the 
majority of injected embryos (Figure 4.4 E). In addition, wild type embryos injected with the 
camk2g2 morpholino showed no defects in ductal convolution, while camk2g1 mutant embryos 
injected with the camk2g2 morpholino showed a loss of convolution in over 90% of injected 
embryos. Cloacal cilia and ear development were not affected by the injection of the camk2g2 
morpholino in either wild type embryos or camk2g1 mutants (Figure 4.4 F). These results 
demonstrate the new-found roles of camk2g2 in camk2g1 deficient embryos. 
 
Camk2g1 CRISPR Mutants Phenocopy Camk2g1 Morphants 
 As camk2g1 mutants develop normally, CRISPR/Cas9 technology was used in an attempt 
to study camk2g1 roles in development. Four non-overlapping guide RNAs were designed to target 
camk2g1. Two were designed to target the 5’UTR. One was designed to target exon1 and the last 
was designed to target exon2 (Figure 4.6 A). The efficacy of the four designed gRNA were 
confirmed by sequencing (Figure 4.7). Embryos injected with the 4 guide RNAs exhibited a variety 
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of phenotypes as would be expected from mosaic expression. However, the majority of injected 
embryos exhibited developmental defects that mimicked camk2g1 morphants. These include tail 
curvatures, brain defects, and smaller otoliths (Figure 4.6 B-G). In addition, kidney cyst were 
visible in approximately 50% of injected embryos by 48hpf (Figure 4.6 E).  
 Expression of all 7 CaMK-II zebrafish genes were assessed in embryos injected with the 4 
guide RNAs targeting camk2g1 using qPCR. The same validated primer set was used as previously 
described (Table 4.1). Analysis of CaMK-II expression in CRISPR mutants shows a statistically 
significant decrease in the presence of both camk2b1 and camk2g1 and a statistically significant 
increase in camk2a expression (Figure 4.6 H) In contrast to camk2g1 mutants, there was no 
statistically significant difference in expression of camk2g2 in CRISPR mutants (Figure 4.6 H). 
This supports the hypothesis that it is the increase in camk2g2 expression in camk2g1 mutants that 
is able to compensation for the absence of its paralog gene, and that this compensation is not 
occurring in embryos mosaically expressing the 4 CRISPR guide RNAs. 
 
Camk2g1 CRISPR mutants exhibit kidney defects that phenocopy Camk2g1 morphants  
  In an effort to further understand the development of camk2g1 CRISPR mutants, kidney 
development was assessed by observing ductal convolution, cell migration, and cloacal defects 
commonly seen in camk2g1 morphants (Rothschild et al, 2011) (Rothschild et al, 2018). 
Approximately 80% of camk2g1 CRISPR mutants pronephric ducts failed to convolute, with 
branching occurring in a subset of embryos (Figure 4.8 A-D). Kidney cell migration was also 
inhibited in camk2g1 CRISPR mutants, demonstrated by the statistically significant increase in 
ear-kidney distance in mutants when compared to control (Figure 4.8 E, p<.05). Cloacal cilia were 
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also affected in mutants, with an average decrease in cloacal cilia present from approximately 11  
cilia in controls (Supplemental Video 4.1) to 5 cilia in mutants, with some possessing no cloacal 
cilia at all (Supplemental video 4.2) (Figure 4.8 F-I, p<.05). Although the number of cloacal cilia 
present was significantly reduced in camk2g1 CRISPR mutants, the length of remaining cilia were 
unchanged when compared to controls (Figure 4.8 J).  This is likely due to the mosaic expression 
in camk2g1 CRISPR mutants. Ductal cilia were unaffected in camk2g1 CRISPR mutants when 
compared to controls (Supplemental Video 4.3 and 4.4). The kidney defects seen in CRISPR 
mutants phenocopies that of camk2g1 morphants, further supporting the specificity of the 
morpholino as well as validating the morphants phenotype seen in current and previous studies.  
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Discussion 
  
 CaMK-II is a serine/threonine protein kinase encoded by 4 genes in humans (α, β, γ, δ) and 
7 in zebrafish (α, β1, β2, γ1, γ2, δ1, δ2). (Tombes et al, 2003) (Rothschild et al, 2009) It is present 
in virtually all tissue types and is known to be involved in variety of cellular functions, from long 
term potentiation to ion channel regulation (Hudman and Schulman, 2002). Through the use of 
knockdown mechanisms such as morpholinos, dominant negatives, and pharmacological 
inhibition, roles of CaMK-II have been expanded to include kidney morphogenesis, left-right 
asymmetry, and inner ear development (Francescatto et al, 2010) (Rothschild et al, 2011) 
(Rothschild et al, 2018). Further studies into the roles of CaMK-II would benefit from the 
development of a stable mutant line in zebrafish. However, this has proven difficult, with some 
CaMK-II genes, namely camk2g1, proving to be resistant to mutations. (Gagnon et al, 2014). 
 In this study, a camk2g1 mutant was generated in zebrafish using TALEN genomic editing. 
Although the use of TALENs was successful in generating a premature stop codon in exon 2 of 
camk2g1, embryos developed normally, with no sign of the defects seen using the previously 
mentioned knockdown mechanisms. This study was able to identify genetic compensation as a 
potential cause for the lack of phenotype in these embryos through the upregulation of a paralog 
gene. It also identified a potential new role for camk2g1 as a regulator for other CaMK-II genes 
expression during development. In addition, this study was also able to validate previous finding 
on the role of CaMK-II though validation of the previously used camk2g1 morpholino.  
 Camk2g1 mutants possess an over three fold increase of the camk2g1 paralog camk2g2. 
Previous publications have described the evolutionary retention of these genetic paralogs and 
redundant (El-Brolosy and Stainier, 2017). However, this terminology implies an almost 
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unnecessary role for these paralogs. The ability of ‘redundant’ genes to compensate for the loss of 
their paralog provides a compelling argument for their evolutionary retention. In the current study, 
the increased expression of camk2g2 in camk2g1 mutants seems to prevent the severe phenotypic 
defects seen in morphants, giving a more defined purpose to its evolutionary retention.  
 Genetic compensation has also been termed “transcriptional adaptation” (El-Brolosy and 
Stainier, 2017). Exactly how the loss of one gene induces compensation of its paralog or a similar 
gene is currently unknown but several pathways have been suggested that include a variety of 
potential signaling partners including chromatin remodelers, transcription factors, and RBPs (El-
Brolosy and Stainier, 2017). Deciphering exactly how transcriptional adaptation occurs requires 
further study. However, genetic knockdown methods are known to not induce genetic 
compensation, it would seem that the presence of mutant mRNA is necessary to induce 
transcriptional adaption either through direct contact with its paralog, or though other epigenetic 
mechanisms. 
 In addition for providing evidence of genetic compensation in camk2g1 mutants, this study 
also supports the use of genetic knockdown methods in developmental studies. Currently, 
knockout methods such as TALEN and CRIPSR/Cas9 are almost required parts of any 
developmental biology study. However, there have been a large number of phenotypic 
discrepancies between mutants and morphants in mice, zebrafish, and cell culture (Kok et al, 2015) 
(Daude et al, 2012) (Karakas et al, 2007). This had led to a distrust in results derived from studies 
using knockdown methods such as morpholinos. It had been suggested that mutants provide a more 
accurate depiction of the roles of a gene of interest and that many of the phenotypes derived from 
knockdown methods are produced from off target effects.  
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 This study in combination with other published works provides evidence that for some 
genes, morpholinos may provide a more accurate phenotype than their mutant counterparts. 
Research have shown that some genes, like camk2g1, can be resistant to mutations (Gagnon et al, 
2014). In addition, the upregulation of camk2g2 in camk2g1 mutants seems to prevent the 
development of the expected morphant phenotype (Rothschild et al, 2011) (Rothschild et al, 2018). 
This upregulation of paralogs or other genetic family members has been seen in other studies where 
mutants and morphants did not possess the same phenotype (Rossi et al, 2015) (She et al, 2019). 
Therefore, it is likely that genetic compensation can account for many of the differences seen 
between morphant and mutants for genes of interest. If this is the case, then embryos that do not 
exhibit compensation, i.e. morphants, may provide a more accurate picture for the roles of a 
particular gene than the mutant in some cases.  
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Figure 4.1. Characterization of camk2g1 mutant zebrafish. Electropherograms of exon2 of 
camk2g1 in wild type and camk2g1 “TALEN” mutant embryos show a loss of 8 nts and gain of 6 
nts leading to a premature stop codon (A). Camk2g1 mutants appear phenotypically normal at 22s 
(B, C), 48hpf (D, E) and 4dpf (F,G). CaMKII specific activity (nmoles/min/mg) is reduced by 25-
30% at 48hpf and 72hpf in camk2g1 mutants when compared to controls (H). 
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Figure 4.2. Camk2g1 mutants injected with camk2g1 MO develop normally. Control, camk2g1 
morphants, camk2g1 mutants, and camk2g1 mutants injected with 1ng of the camk2g1 MO were 
imaged at 48hpf (A-L). Camk2g1 morphants display curved tails (B) smaller otoliths (F) and 
defects in cloacal morphology (J). Control embryos, camk2g1 mutants, and camk2g1 mutants 
injected with the camk2g1 MO do not display such morphological defects. CaMKII activity assays 
of 72hpf embryos reveal twice the reduction in CaMKII activity in camk2g1 morphants injected 
with 0.5ng or 1.0ng of camk2g1 MO, when compared to camk2g1 mutants (M). 
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Figure 4.3. Normal kidney development in camk2g1 mutants injected with the camk2g1 MO. 
Anterior convolution was assessed at 72hpf in control, camk2g1 morphants, camk2g1 mutants, and 
camk2g1 mutants injected with camk2g1 morpholino by immunostaining the kidney specific 
NaKATPase (A-D). Quantification of convolution in the anterior pronephric duct (E). Analysis of 
cellular migration at 72hpf in the pronephric duct by measuring the distance between the posterior 
ear and anterior kidney (F). Cloacal cilia number (G) and length (H) were assayed at 72hpf. 
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Figure 4.4. Molecular and Functional Compensation of camk2g1 mutants by camk2g2. qPCR 
of CaMK-II genes in camk2g1 mutants at 24hpf relative to ef1α (A). Percentage of clones 
attributed to each CaMK-II gene after amplification and sequencing of variable domains in control 
and camk2g1 mutants at 24hpf (n=15-18) as previously described (B) (Rothschild et al., 2007). 
CaMK-II splice variant exon utilization falls into specific categories (C) (Rothschild et al., 2007). 
CaMK-II splice variants denoted by gene and categories that were observed in control and 
camk2g1 TALEN mutant embryos. Previously unreported splice variants of camk2g2 are colored 
red (D). Cardiac asymmetry was evaluated at 24hpf by live embryo observation under indicated 
conditions (E). Convolution was assessed by examining immunostained embryos using the kidney 
specific NaKATPase (F). 
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Figure 4.5. Relative mRNA Fold Change at 48hpf in camk2g1 Mutants. Relative fold change 
of CaMK-II genes in camk2g1 mutants relative to ef1α. Camk2g2 shows a statistically significant 
increase in expression in camk2g1 mutants. Camk2b2, camk2d1, and camk2a show a statistically 
significant decrease in expression in camk2g1 mutants.  
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Figure 4.6. Morphological Defects in camk2g1 CRISPR Embryos. 4 gRNAs were designed 
against camk2g1 to generate G0 camk2g1 CRISPR embryos (A). G0 camk2g1 CRISPR embryos 
show variable phenotypes with shortened anterior posterior axis and tail curvatures evident at 
48hpf (C) compared to control embryos (B). Kidney cysts develop by 48hpf (E, asterisks) and 
were absent in control embryos (D). Otoliths were smaller in camk2g1 CRISPR embryos when 
compared to controls (F, G). Dorsal, anterior to the left (D, E). Lateral, anterior to the left (F, G). 
qPCR of CaMK-II genes in camk2g1 CRISPR embryos at 24hpf relative to ef1α 
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Figure 4.7. Genomic confirmation of camk2g1 CRISPR embryos. Twenty pooled embryos 
were sequenced using the sense primer for each of the four gRNA target sequences. 
Electropherograms for control and camk2g1 CRISPR embryos confirmed insertion/deletions of 
each gRNA target.  
 
102 
 
 
Figure 4.8. Kidney defects in camk2g1 CRISPR embryos. Anterior convolution is reduced in 
camk2g1 CRISPR embryos compared to controls at 72hpf (A-D). The ear-kidney distance is 
increased in camk2g1 CRISPR embryos at 72hpf (E). Cloacal cilia number is reduced in camk2g1 
CRISPR embryos (F-I). However, length of remaining cloacal cilia in camk2g1 CRISPR embryos 
is unchained when compared to control embryos (J). 
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Supplemental Video 4.1. Control embryos have beating cloacal cilia at 72hpf . Shown at 20 
frames per second.  
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Supplemental Video 4.2. Camk2g1 CRISPR embryos lack beating cilia at 72hpf. Shown at 20 
frames per second.  
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Supplemental Video 4.3. Control embryos have beating ductal cilia at 72hpf. Shown at 20 
frames per second. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
 
Supplemental Video 4.4. Camk2g1 CRISPR embryos have ductal cilia beating at 72hpf. 
Shown at 20 frames per second. 
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Gene Primer (5’ – 3’) 
S camk2a GTCGCAGGATCAGTCGTTTGAG 
AS camk2a GCAACAGCAAAGTGGCTTCATC 
S camk2b1 GCTCTCCAAGAACAGTAAGCCC 
AS camk2b1 GACATTCTGCCATTTGGAGTCC 
S camk2b2 GAACAGTAAACCGATCCACACC 
AS camk2b2 GAGCAGTGGAAGTGAATGTTCTG 
S camk2g1 GCCTGGATTCTCGAGATAATGG 
AS camk2g1 CTCCCGTTGGTCAAAGATTGGAC 
S camk2g2 GATGCTGCATGCTTCTAATGTC 
AS camk2g2 GTTTCAAACCTCCACCTCTACC 
S camk2d1 CAGCTGAGCTTCAACAAGTGTC 
AS camk2d1 CTGAAATGATTCTCCAGCTCTC 
S camk2d2 GGAGAAACCATCAGCAAAAACC 
AS camk2d2 CTTGAACTCTCTGGTCCATGTG 
  
Table 4.1 qPCR Primers. Primers targeted for the 7 CaMK-II in zebrafish for amplification in 
qPCR. All primers were designed to target the 3’UTR except camk2b1 and camk2b2 which were 
designed to target the association domain.  
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Chapter 5: Reduction of camk2g1 Activity in Zebrafish Reveal Novel Roles of CaMK-II in 
Kidney Morphogenesis that may be Imperceptible in Mutant Models Due to Genetic 
Compensation.  
 
 Since their initial use as a model organism in the 1970s, zebrafish have emerged as an 
essential tool for developmental studies and disease modeling. Their quick developmental time, 
high rate of gene conservation with humans, and relatively low husbandry cost have enabled 
zebrafish to be used in a variety of different research fields. For this study, which focuses on kidney 
development and ADPKD modeling, their transparency during development has enabled real time 
imaging of pronephric development and the identification of potential therapeutic targets for 
ADPKD patients.  
 Previous research identified CaMK-II, a serine/threonine protein kinase, as a downstream 
target of Ca2+ flux though the cation channel formed by PKD2, one the genes most commonly 
mutated in ADPKD patients. Once activated, CaMK-II acts to regulate a number of pronephric 
developmental processes including cell migration, ductal convolution, and cloacal cilia 
development and stability. Inhibition of camk2g1, the predominant form of CaMK-II in the 
zebrafish kidney, not only disrupts the previously mentioned processes, but also causes the 
development of anterior kidney cysts. The addition of a constitutively active form of CaMK-II was 
able to inhibit cyst development, as well as prevent other pronephric defects seen in camk2g1 
morphants.  
 This study expands upon the previously established role of CaMK-II in pronephric 
development by identifying its regulation of histone deacetylase 4 (HDAC4) as necessary for 
kidney morphogenesis. Histone deacetylases are known regulators of gene transcription whose 
presence in the nucleus causes the condensing of chromatin, preventing transcription of its target 
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genes. In in study, hdac4 was localized predominantly in the cytosol during pronephric 
development. The suppression of camk2g1 caused the subcellular translocation of hdac4 from the 
cytosol to the nucleus, thereby preventing transcription of genes normally active during 
organogenesis. Co-inhibition of hdac4 was able to rescue ductal convolution defects seen in 
camk2g1 morphants, identifying histone deacetylases as a potential new target for treatments for 
ADPKD. However, caution should be used as suppression of hdac5 exacerbated defects in 
camk2g1 morphants.  
 Further studies into this pathway should focus on identifying other downstream targets. 
Potential targets identified by this study include notch signaling proteins. Inhibition of camk2g1 
caused the loss of the notch response element tp1 in the cloaca and the increase in expression of 
the notch ligand deltaC. Similar to earlier studies, the expression of deltaC could be rescued in 
camk2g1 morphants with suppression of hdac4 suggesting that notch signaling proteins may be 
downstream members of that pathway, and a potential target for treatments for ADPKD. Future 
studies should focus on understanding the connections between these pathways by analysis of other 
notch signaling proteins in camk2g1 morphants, such as notch3 and jagged2 in order to identify 
specifically what notch proteins are being affected. 
 In addition to identifying the regulation of HDAC4 by CaMK-II, this study also further 
demonstrates the multifactorial roles of CaMK-II during kidney development. Inhibition of hdac4 
was able to rescue ductal convolution in camk2g1 morphants, but it was unable to rescue cell 
migration. This suggests that the processes of ductal convolution and cell migration are separate 
and that CaMK-II plays an integral role in both pathways.  Pronephric cells migrate at a slower 
rate in camk2g1 morphants when compared to controls, never reaching the site where they should 
convolute inward to connect with the glomerulus. In an effort to understand this reduction in 
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cellular migration rate, this study has identified two potential causes for this defect. One is the 
increase in expression of the extracellular matrix protein collagen. In camk2g1 morphant, 
expression of the ECM protein col2a1a was increased, mimicking the expression previously seen 
in pkd2 morphants. Increase in collagen expression may be a potential cause for the decreased 
migration as increased collagen expression is associated with reduced migratory capabilities, 
caused by an increase in focal adhesion attraction to the ECM. This is also supported by the partial 
rescue of convolution seen in camk2g1 morphants treated with the secretory inhibitor, Brefeldin 
A (BFA).  Future research into this area would benefit from the analysis of kidney specific collagen 
protein as well as well as more specific mean of inhibiting collagen secretion as BFA inhibits all 
COP II dependent secretory pathways and is likely inhibiting other necessary pathways. 
 This research, as well as previous studies, has relied heavily upon the use of knockdown 
mechanisms such as morpholinos, dominant negatives, and pharmacological inhibitors. Currently, 
the generation of genetic mutants has become a new standard for developmental research. A 
mutant for camk2g1 was generated in zebrafish using TALENs. However, the mutants displayed 
none of the defects seen in previously studies using knockdown methods. This occurrence is not 
unique to this study, as there have been many other previously reported discrepancies between 
mutants and morphants in various model organisms. In this case, genetic compensation seems to 
be the cause of the lack of phenotype in camk2g1 mutants. qPCR analysis of the 7 CaMK-II genes 
present in zebrafish  identified a 3 fold increase in the expression of the camk2g1 paralog, camk2g2 
in mutants when compared to controls, preventing any defects caused by the loss of camk2g1. This 
study also demonstrated that compensation by a paralog gene is not an immediate occurrence, as 
G0 camk2g1 CRISPR embryos did not display the same increase in camk2g2 expression and 
possessed nearly all of the morphological defects seen previously in camk2g1 morphants. These 
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results support the findings of previous studies using knockdown mechanisms such as 
morpholinos, as genetic compensation may occur in mutant models, inhibiting any reverse genetic 
studies. Future studies should focus on using the compensatory ability of CaMK-II paralogs to 
determine how and when compensation in initiated. Generational studies with stable lines 
generated with the 4 gRNAs for camk2g1 could be used in conjunction with qPCR analysis to 
determine if compensation by camk2g2 is initiated with the first stable generation or if it is 
developed over several generations.  
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